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ABSTRACT
The physicochemical properties of the melanophore- 
concentrating hormone (MCH) of teleost pituitaries were 
studied. It was found to be a heat-stable trypsin- 
sensitive peptide of about 1 700 daltons which was 
similar in charge, size and hydrophobicity to a-MSH. 
Partial purification by cation-exchange, gel-filtration 
and HPLC showed that it was not identical with any 
of the melanocyte-stimulating hormones (MSH*s) of 
teleost pituitary, but the possibility that these 
peptides are structurally related could not be excluded 
Both hypothalamic and pituitary forms of MCH were 
distinguished from the known neurohypophysial hormones 
by their size and their insensitivity to reduction with 
thiol-reagents. Complete purification of a-MSH's 
showed that these were present in greater amounts, 
than was MCH in the pituitary. The implications of 
this are discussed recommending the hypothalamus 
rather than the pituitary for the purification of 
MCH. Since melanophore-concentrating activity could 
be masked in crude hypothalamic extracts,MCH may have 
a wider phylogeny than has been previously appreciated.
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The spectacular ability of certain animals to change 
their colour has intrigued man for centuries. The 
process is brought about by the redistribution of 
pigment organelles within specialised integumental cells 
of neural-crest origin known as chromatophores. In 
lower vertebrates colour-change is largely an adaptive 
measure to maintain camouflage despite changes in 
background. The predominant pigment is melanin, and 
animals appear pale when pigment is concentrated 
centripetally around the nucleus of the melanophore, 
and dark when it is dispersed centrifugally through­
out the cytoplasm.
Colour-change by alteration of the intracellular 
distribution of pigment is known as physiological 
colour-change as distinct from morphological colour- 
change where changes in the number and pigment content 
of melanophores also occur. This report will be 
primarily concerned with physiological colour-change 
and any unqualified reference to "colour-change" will 
imply the physiological type.
1.1 The role of the .pars, intermedia in background adaptation
The pars intermedia (PI) of the amphibian pituitary has 
long been known to be the source of melanophore-
dispersing hormones, and injection of pituitary-extracts 
causes melanophore-dispersion. Teleosts however, may 
either pale or darken when injected with pituitary 
extracts depending on the species of donor and 
recipient (see Pickford and Atz 1957) . They are also 
unique in having two histologically distinct cell-types 
in the PI ; these are named according to their reaction 
with lead-haematoxylin (PbH) and periodic-acid-Schiff 
(PAS) stains as the PbH+ and PAS+ cells (St^hl, 1958) . 
(Salmonids do not have a PAS+ cell but a chromophobic 
cell-type which may be an homologue of the PAS+ cell 
( Ball and Baker 1969) ) . Stahl (1958), to explain the 
dual character of teleost pituitary extracts, postulated 
that these cell-types were the sources of antagonistic 
melanophore-controlling hormones. Since then, the 
cytophysiology of the PI has been studied in relation 
to background (Tab 1). The PI cells show evidence of 
increased secretory activity during adaptation to B, 
and decreased activity during adaptation to W; the 
cell-type affected depends on the species. However, 
in no case was PI cell activation associated with W 
adaptation and therefore Stahl’s hypothesis is no 
longer tenable.
a) The+PbH+ cell
The increased granulation seen in the PbH+ cell in 
B-adapted Anguilla soon after transfer to W was shown 
to be correlated with an increase in bioactive MSH-
Table 1. The response of the pars intermedia cells 
of teleosts to black background.
Group 1
PbH+ cell activated 
predominantly
Anguilla, Salmo, Phoxinus, Tinea
Group 2
PAS+ cell activated Poecilia, Cichlasoma, Blennius
Group 3
PbH+ and PAS+ cell 
activated
1 2  3 Sarotherodon , Boops, Scorpaena
Group 4
Neither cell type 
activated
Ictalurus, Heterpneustes
The PI cells become activated only in response to 
black background, transfer to white background causes 
regression.
Salmo could belong to group 3 as the response of its 
"PAS+ cell" (actually a chromophobe -see text) has not 
been determined. The group classification is that of 
Ball and Batten (1981) except that I have included 
Ictalurus and Heteropneustes as an extra group. The 
information for groups 1, 2 and 4 is from Ball and 
Baker (1969), Baker and Ball (1970) and Baker (1981). 
It may be significant that in Anguilla, Ictalurus 
and Heteropneustes, where innervation of melanophores 
is rudimentary, they respond to teleost pituitary 
extracts by dispersion and not by concentration as 
do most of (if not all) the others in this table.
1. Van Eys(1980), 2. Malo-Michele (1977a), 3. Malo- 
Michele (1977b).
content of the neurointermediate lobe (NIL)- indicating 
that this cell-type is the melanotrope (Baker,
1972). In this species, melanophore dispersion 
is associated with PbH+ cell activation as seen when 
this is provoked or suppressed independently of 
background by injections of drugs such as metopirone 
or reserpine (which cause activation) and 6-hydroxy- 
dopamine or cortisol (which cause regression)(see 
Holmes and Ball, 1974).
The reactivity of the PI cells towards antisera 
raised against mammalian a-MSH and ACTH is confined 
to the PbH+ cell confirming its identity as the 
melanotrope (Follenius and Dubois, 1974, 1980; Romain 
et al, 1974 ; Malo-Michele et al, 1976 ; Olivereau et 
al 1976.'). This is even true of species such as
Poecilia where the PAS+ cell is active on B (Dr.
B. Baker, personal communication).
b) The PAS+ cell
Although the PAS+ cell is clearly activated by B in 
teleosts such as Poecilia and Sarotherodon, the 
nature of its secretory product(s) is unknown.
In Sarotherodon the PAS+ cell reacts with mammalian 
prolactin antisera, but this immunoreactivity is not 
attributable to teleost prolactin (Rawdon 1979) . In
hypophysectomised Fundulus, chronic administration 
of sheep prolactin causes melanization of dorsal 
melanophores (Pickford and Kosto, 1957). Although 
there might not be a causal link between these 
observations, they constitute circumstantial evidence 
for the secretion of a prolactin-like melanotropic 
hormone (not prolactin) by the PAS+ cell, which is 
active in morphological colour-change.
In species where both PI cell-types are active on 
B, their secretory products may interact in some way 
or complement each-others* .action. In this regard 
it is noteworthy that Pickford and Kosto (1957) also 
found that g-MSH caused recruitment of melanophores 
(i.e. was complementary to prolactin).
Notably, Sarotherodon prolactin is 24 residues shorter 
than its mammalian counterpart (Farmer et al, 1977), 
and the PAS+ cell's immunoreactivity may mean that 
it contains a variant prolactin which is more akin to 
the mammalian hormone.
1*2 Physiological colour-change in teleosts
a) The role of nerves
Physiological colour-change in many teleosts is very 
rapid, adaptation to background reversal often being 
accomplished in a few minutes. This is because their
melanophores (unlike those of elasmobranchs and 
amphibians) are controlled predominantly by nerves.
Many investigators have demonstrated the potent 
concentrating effects of noradrenaline, dopamine and 
adrenaline - both in vivo and in vitro - and there is 
little doubt that concentration is evoked by the release 
of a catecholamine neurotransmitter from sympathetic 
nerve-terminals close to the melanophores, which acts 
on a-adrenoceptors (:see Bagnara and Hadley 1973) ; '
There is also evidence that in some species, dis­
persion is assis ted by nerves which may act via g- 
adrenoceptors. Thus, injections of p-adrenergic agonists 
caused dispersion in the freshwater angelfish Pterophylum 
eimekei(Finnin and Reed, 1970), and low doses of 
natural catecholamines (especially adrenaline) as 
well as synthetic g-agonists, caused dispersion in 
Poecilia reticulata (formerly Lebistes reticulatus) 
(Miyashita and Fujii, 1975). The presence of p- 
receptors which can mediate dispersion does not 
necessarily indicate the existence of dispersing 
innervation; neither does the dispersing effect of 
certain types of electrical-stimulation, as pointed 
out by Fujii and Novales ( 196'9a) . No support has 
emerged for the early notion of Parker (1948)that 
acetylcholine was the dispersing neurotransmitter.
b) The role of hormones
Melatonin is well known for its paling action on 
larval amphibians. It is also active in certain 
teleosts. The melanophores of embryonic and larval 
forms of Fundulus concentrate in response to melatonin 
both in vivo and in vitro, although adult forms 
are insensitive (Nichols et al, 1965; Fain and Hadley, 
1966). Even the adult forms of some species (e.g.Salmo 
gairdneri) (Hafeez, 1970) respond to melatonin, 
but only in vivo. The absence of an in vitro response 
(Reed et al, 1969) indicates that the action is 
indirect - perhaps mediated by nerves ; or, considering 
the very high doses necessary for the in vivo response - 
it could be a stress reaction. Although variations 
in plasma melatonin concentration have been observed 
in response to illumination (Owens et al, 1978, in 
Salmo gairdneri), such variations do not occur in 
response to background.
These responses to melatonin may be the vestige of 
an archaic mechanism of colour-change where melatonin 
was once a paling hormone, but it is unlikely that 
melatonin has a direct hormonal role in todays 
teleosts.
Although fish may exhibit pallor in response to 
intense stress - presumably due to adrenaline and 
noradrenaline from the chromaffin cells, it is considered
8unlikely that this mechanism is involved in adaptative 
physiological colour-change.
Pituitary hormones on the other hand, do appear to 
be.Involved in physiological colour-change. The 
innervation of teleost melanophores and their extreme 
sensitivity to catecholamines has hindered the elucidation 
of the role pituitary hormones play in their control; 
this - and their great diversity as a phylogenetic 
group - sets teleosts apart from amphibians where the 
simple experimental approach of hypophysectomy / 
replacement therapy has yielded relatively unambiguous 
results.
1.3 The two-hormone hypothesis
Whilst there is considerable evidence that - at 
least in some teleost species - a pituitary melanophore- 
dispersing-hormone operates, the participation of a 
melanophore-concentrating hormone is a contentious 
issue. That two opposing hormones participate in 
physiological colour-change: the "two hormone hypothesis" 
was first postulated by Hogben and Slome (1931) to 
explain the results of their experiments with Xenopus.
This interpretation was criticised by Kent (1959b) 
and by Waring (1963) and refuted by the findings of 
Barker-Jorgensen (1962): a crucial tenet of the two 
hormone hypothesis was that hypophysectomised Xenopus
were not maximally pale, but this was shown to be 
false by Barker-J(j)rgensen who showed that the hypo­
physectomy technique used by Hogben and Slome almost 
certainly resulted in incomplete removal of the 
pituitary, and that totally hypophysectomised animals 
were indeed maximally pale.
In the meantime, the two-hormone hypothesis had been 
invoked by students of Hogben (Neill, 1940; Healey,1951) 
to explain background responses in teleosts. This 
interpretation has been criticised (for the cases of 
both amphibians and teleosts) by Kent (1959b) who 
showed that some of the arguments for the two-hormone 
hypothesis were based on the invalid comparison of 
rates of adaptation to darkness with those of back­
ground reversal. Nevertheless, there remain a number 
of features of the background responses of teleosts 
which are difficult to reconcile in terms of one hormone. 
One such feature is the capacity of teleost pituitary 
extracts to induce pallor when injected into fellow 
teleosts (see Pickford and Atz 1957). Comparatively 
recently however, it has become apparent that the 
teleost pituitary is exceptionally rich in aminergic 
nerve-terminals - a feature of its peculiar mode of 
control by the hypothalamus (see Holmes and Ball 1974). 
Since teleost melanophores are highly sensitive to 
catecholamines, an obvious possibility (especially 
pertinent in view of the high doses necessary) is 
that the paling activity of pituitary extracts was
10
a pharmacological effect of catecholamines. Crucial 
therefore, to the concept of an MCH is the nature 
of the paling agent of teleost pituitary extracts.
A number of workers have investigated this but the 
factor has never been isolated. Thus ; Kent (1961) 
found that melanophore-dispersing and melanophore - 
concentrating activities (assayed using frog and 
minnow bioassays respectively ) were inseparable 
by paper electrophoresis at a variety of pH*s.
He concluded that both activities were due to the same 
molecule, and that it was a peptide. Baker and Ball 
(1975) however, using the higher resolution technique 
of disk electrophoresis in polyacrylamide gels, were 
able to seperate multiple forms of MSH - none of which 
exactly co-migrated with MCH. These data are consistent 
with its putative peptidic nature and suggest that it 
is neither a type of MSH nor a catecholamine.
In their review of colour-change in lower vertebrates 
in 1968, Bradshaw and Waring re-evaluated the existing 
data, and concluded that hormonal control of the 
background responses of teleosts (as well as amphibia) 
was exerted soley by a dispersing hormone. Though 
they pointed out a number of inconsistencies with 
this interpretation, they felt that these did not 
warrant the postulation of a concentrating hormone in 
addition. Earlier, Waring had been a protagonist of 
the two-hormone hypothesis in teleosts and consequently
11
the 'melanophore-concentrating hormone' has been 
somewhat neglected since then.
In the eel Anguilla, where innervation is rudimentary, 
hypophysectomy severely impairs black background 
adaptation, full dispersiai is restored by injection 
of pituitary extracts, and there is a clear case for 
the participation of MSH (Waring, 1953) . The catfish 
Ictalurus behaves similarly, though nerves play a 
more active role in the paling process (Khokhar, 1970, 
1971a»b). In neither case is an MCH thought to be , 
involved in the paling process.
The evidence for an MCH comes from species where nerves 
have a dominant role in background adaptation and 
hypophysectomy has little or no effect thereon. To 
demonstrate the action of hormones therefore, and to 
preclude the participation of nerves, workers have 
applied a variety of de nervation techniques. Thus 
Healey (1948) has shown that minnows subjected to 
spinal section are still capable of background 
adaptation although its rate and extent are impaired 
by the operation. When spinally operated animals were 
hypophysectomised, even this limited ability was lost 
resulting in a permanently dark state. There is an 
obvious case here for an MCH. However, Grove (1969b) 
later showed that injection of the a-adrenergic 
antagonist Rogitine caused dispersion in minnows which 
were ostensibly pale due to circulating MCH which would
12
suggest that the pale state was due to circulating 
catecholamines rather than an MCH.
Baker and Ball (1975) have studied the effects of 
hypophysectomy on denervated melanophores of Poecilia. 
These workers used the fin-ray section technique of 
Parker (1948) to produce denervated caudal bands. 
Hypophysectomy alone (with intact innervation) reduced 
the extent of dispersion attainable on a black back­
ground suggesting a pituitary MSH might be involved in 
this response. (The extent of melanophore concentration 
attainable on a white background however, was unimpaired 
by hypophysectomy). In fish with denervated caudal 
bands, hypophysectomy delayed the onset of, and 
impaired the extent of white background adaptation.
These workers noted the paling action of injected 
teleost pituitary extracts but in addition showed that 
extracts of the piuitary of Squalus (an elasmobranch) 
cause dispersion and - paradoxically - synthetic a-MSH 
caused slight concentration. They considered that 
these results supported the two-hormone hypothesis 
i.e. that pituitary control of melanophores was dual 
in character.
In evaluating the data which bears on the two-horomne 
hypothesis, it is important to consider some of the 
vagaries of the experimental methods used. Thus,
Grove (1969a) compared the effects of spinal section 
and spinal-nerve section in Phoxinus. (The former is
13
section of the spinal cord anterior to the site of 
exit of the chromatic nerve fibres, the latter is 
section of the segmental spinal nerves distal to their 
exit from the segmental sympathetic ganglia). Grove 
concluded that the relatively rapid recovery of 
melanophore response in the denervated area resulting 
from the post-ganglionic section of segmental spinal 
nerves, was due to diffusion of neurotransmitter 
from neighbouring unaffected areas of skin. He also 
noted the long-term development of hypersensitivity 
to catecholamines in denervated melanophores (especially 
those which had been subject to post-ganglionic section).
Fujii and Novales (1959a)in their study of the nervous 
control of Fundulus melanophores used the caudal fin 
denervation technique of Parker (1948) and attributed 
paling in this region (in response to electrical 
stimulation) to diffusion of neurotransmitter as 
did Grove (1959à). They also noted (ig69b) in support 
of this explanation that, typically, nerves terminated 
close to - but not on - melanophores. However, Baker 
and Ball (1975) have attributed paling of denervated 
caudal bands (of Poecilia) to M C H -  since this process 
was impaired by hypophysectomy. It would seem 
therefore, that both circulating MCH and diffused 
neurotransmitter are involved.
In teleosts where innervation of the melanophores is 
highly developed - in contrast to the eel - there is
14
little evidence for the involvement of an MSH in 
physiological colour-change. In vitro studies have 
shown that in Oryzias latipes, a-MSH neither stimulates 
melanophores to disperse, nor does it accelerate the 
spontaneous dispersion which occurs in the absence 
of catecholamines (Negishi and Obika, 1980). Lack 
of response of teleost melanophores to mammalian 
hormones could be due to species differences in the 
structure of the hormones, but the close homology of 
mammalian and teleostean MSH's (Kawauchi and Muramoto, 
1979; Kawauchi et al 1980a,b) would argue àgainst this.
Recently, using a radioimmunoassay for a-MSH, Mr.
T. Bowley of this laboratory has shown that plasma 
MSH titres in Salmo qairdneri are highest in fish 
adapted to black background. This is the first time 
circulating MSH has been measured in teleosts and is 
an important step in establishing hormonal status as it 
corroborates the PI PbH+ cell activation which occurs 
in this species. Considering this, in the context 
of the foregoing, it is more likely that (in fishes 
with dominant concentrating innervation) MSH is 
involved in morphological rather than physiological 
colour-change. (MSH could theoretically be involved in 
both but the evidence for a physiological role is 
lacking).
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1.4 The source of MCH
Healey (1948) used partial hypophysectomy in spinal- 
sectioned Phoxinus and found that some of the anterior 
pituitary was required for maintenance of W response. 
Complete hypophysectomy abolished this response, and 
he concluded therefore that MCH was produced in the 
pars distalis (PD). By injecting homogenates of 
dissected pituitaries into Phoxinus, Kent (1959a) 
found - in contrast - that there was more MCH in 
the posterior half of the gland (i.e. the NIL).
Using an in vitro bioassay, Enami (1955) showed that 
in the oriental catfish, Parasilurus asotus, MCH was 
localised mainly in the posterior part of the anterior 
pituitary (the proximal pars distalis or PPD) as well 
as in the hypothalamus. He tentatively suggested that 
MCH was a type of neurosecretory hormone (i.e. a 
neurohypophysial hormone). If this were so it could 
explain the apparently discrepant observations of Healey 
and of Kent in Phoxinus.
A hypothalamic origin for MCH has also been suggested 
by Ranee and Baker (1979) who found, with an in vitro 
assay, that the distribution of MCH between hypothalamus 
and pituitary of Salmo qairdneri varied according to 
background: whereas W-adapted fish had similar amounts 
at each site, in B-adapted fish more was found in 
the hypothalamus. They supposed that Kent's (1959a)
16
failure to detect MCH in the hypothalamus of Phoxinus 
may have been because his fish were W-adapted.
They also found that the release of MSH from cultured 
NIL'S was inhibited by cold, cycloheximide (a protein 
synthesis inhibitor), EGTA (a calcium ion chelating 
agent) and potassium ions, whereas that of MCH was 
erratic and not demonstrably affected by any of these 
treatments. These findings were cited in favour of 
an extra-pituitary site of biosynthesis (i.e. the 
hypothalamus) and it was suggested that the sporadic 
release of MCH might be due to the degeneration of 
MCH-containing axons.
1.5 MCH as a type of neurohypophysial hormone
The concept bf MCH as a type of neurohypophysial 
hormone is attractive initially as it would explain 
the lack of cytophysiological evidence that either of 
the PI cells secretes a hormone during W-adaptation. 
However, there is no evidence that the neurohypophysis 
(NH) does so either, and a recent study of the effects 
of background on the cytology of the pituitary of 
Poecilia notes a lack of effect on the neurohypophsial 
elements (Ball and Batten, 1981). However, the secretion 
of a neurohypophysial hormone might not necessarily 
result in an observable change in the NH, although 
changes in features such as axon-terminal granule 
content and the amount of stainable neurosecretory
17
material present in the NH have been associated with 
osmoregulation (Lederis, 1963, 1964; Abraham, 197 6), 
stress (Leatherland and Dodd, 1969) and with repro­
duction - see Perks (1969) for review.
The distribution of MCH between the hypothalamus and 
the pituitary described by Ranee and Baker (1979) 
is contrary to that of the known neurohypophysial 
hormones where there is more in the pituitary due to 
storage in the axon-terminals of the NH. However, 
we know too little about the endocrinology of the 
neurohypophysial hormones of teleosts to regard this as 
necessarily inconsistent with the putative identity 
of MCH as a neurohypophysial hormone.
The apparent confinement of MCH to teleosts, or 
rather its absence from mammals, has meant that it 
has attracted little attention of late. However, the 
ever-increasing realization of the extent of homology 
which exists among hormones and related substances 
across phylogenetic boundaries puts MCH in a more 
attractive light - as a search for homologues in other 
species might reveal new hormones. Whether MCH is 
truly a hormone and whether it has homologues in other 
species are questions which await its purification, 
structural elucidation and further experiment.
There have been no published attempts at the outright
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Rainbow trout (Salmo qairdneri ) aged 1-2 yr (immature) 
were obtained from a local fish-farm (Alderley Trout Ltd., 
Alderley, Wooton Under-Edge). They were moderately 
dark on arrival at the laboratory and thereafter were 
kept in black or white tanks of aerated water (l701itres), 
without feeding, at lO^C with overhead illumination 
for a daily photoperiod of 16h.
2.2 Removal of pituitary dlands and hypothalami
Fish were killed by decapitation and the roof of 
the cranium was sliced off. Grasping the spinal 
cord, the brain was lifted upwards and forwards 
(cutting nerves where necessary) far enough to 
expose the ventral pituitary; this resulted in 
severance of the pituitary stalk leaving the pituitary 
in situ and conveniently exposing the hypothalamus, for 
dissection. The pituitary was then removed with a 
pair of fine forceps which were committed to this 
purpose to avoid cross-contamination of pituitary 
and hypothalamic extracts.
With the ventral surface of the brain uppermost, 
transverse cuts were made just posterior to the 
optic chiasma-and just anterior to the saccus 













Diagram of the brain and pituitary gland of Salmo 
Gairdneri in saggital l.s. showing approximately the 
region of hypothalamus taken as source of MCH (broken 
line). The graph shows the MCH content of horizontal 
sections of brain determined after removal of the pituitary 
in the region denoted by the arrows. This region 
includes the posterior PON dorsally (not in this section) 
which extends around the lateral walls of the third 
ventricle, and also the NLT ventrally. The region 
excised probably includes, on average, the major bio­
active peak of the ventral hypothalamus and also some of 
the upper peak. These data are unpublished observations 
of Drs. Ranee and Baker of this laboratory. SC=sub- 
commisural organ, PC=posterior commisure, PON=preoptic 
nucleus, IIIv=third ventricle, NLT=nucleus lateralis 
tuberis, PD-and PI=pars distalis and intermedia of the 
pituitary, SV=saccus vasculosus.
21
third-ventricle between these cuts was then excised 
to a depth of about 3mm with a single horizontal cut 
with a pair of scissors. Fig. 1 shows the region 
excised by this procedure. Pituitaries and hypothalami 
were transferred to solid CO2 immediately after 
removal. When sufficient had been collected, they 
were homogenised (hypothalmi first to avoid cross­
contamination) . With practise the pituitary and 
hypothalamus could be dissected and placed on solid 
CO2 within 30 - 40s of the fish being alive.
2.3 Commercial pituitary powders
Because availability of fresh material was limited, 
commercial preparations of salmon (Onchorynchus 
keta) pituitaries were used for the purification of 
peptides. These were prepared by Syndel Laboratories 
of Vancouver, Canada, and supplied by Windsor 
Laboratories (formerly International Enzymes) of 
Sloughy Bucks. At first, acetone-dried pituitaries were 
used, but because of the possibility that small 
peptides had been lost during preparation, a special 
batch of lyophilized pituitaries was obtained.
These had been lyophilized directly from the frozen 
state without prior extraction. According to the 
suppliers, for each preparation dry weight / wet 
weight = 0.2, and Ig = 192 pituitaries.
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2.4 Extraction procedures
Fresh tissue was homogenised either in 0.IM HCl or in 
IM acetic-acid. An Ultra-Turrax homogeniser type 
TP18-10 was used at 20k Hz for 30s. Where smaller 
volumes (less than 5 ml) precluded the use of 
this homogeniser, tissue was sonicated at 20k Hz 
for 30s at ICÿum amplitude using an MSE lOOW sonicator 
with a 3mm terminal-diameter titanium probe. Where 
homogenisation was performed in boiling acetic- 
acid, fragments of frozen tissue were dropped directly 
into the boiling acid. (This was to minimise the 
risk of proteolysis which is serious when tissue is 
thawed, because of the rupture of lysosomal and other 
membranes caused by freezing). Pituitary homogenates 
were centrifuged at 2,400g for 20min and the pellet 
discarded. Hypothalamic homogenates treated in this 
way yielded a turbid supernatant, even when centrifuged 
at 9,000g. This was overcome by defatting the 
homogenate using chloroform / methanol according to 
Bligh and Dyer (1959), the resulting aqueous methanol 
phase was taken.
In the case of commercially prepared pituitary powders, 
0.IM HCl gave poor solubilization, and therefore IM 
acetic-acid (100ml per gram of powder) was used 
exclusively. Because, even with acetic-acid, the 
powders were more difficult to solubilize than fresh 
tissue, homogenization was for 5min in 30s episodes.
23
For chromatography, extracts were lyophilized and 
reconstituted in the running solvent.
2.5 Bioassay for MCH
The MCH bioassay was performed as outlined by Ranee 
and Baker (1979). When a trout scale is placed in 
a physiological-salts solution containing MCH, the 
melanophores exhibit melanin-aggregation in a few 
minutes; both the rate and the extent depend on 
the MCH concentration of the solution. The assay is 
basically a titration whereby dilutions of a sample 
are tested in this way until one is found which will 
induce half-maximal melanophore-aggregation in 20 min. 
This dilution is known as the "threshold dilution".
The activity of a sample in trout units (TU) is 
the reciprocal of this dilution X the volume of 
the sample expressed in tenths of a ml. For example:
if the threshold dilution = 1/100
and the sample volume = 0 .2ml
then MCH activity =100/1 X 0.2ml = 20ml
=200TU
In practice the threshold dilution is rarely found 
and is estimated by interpolation between determinations 
either side of it. For each determination at 
least three scales were used.
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Because of variation between batches of scales the 
trout unit is not an absolute measure and comparison 
can only be made within an assay. To compare between 
assays, a reference standard was prepared from the 
commercial acetone-dried salmon pituitary powder. An 
acetic-acid extract (unheated - see extraction 
procedures) was lyophilised in aliquots equivalent 
to Img of powder in 1.5ml conical polypropylene 
centrifuge tubes. These were then rigorously 
dessicated over and NaOH and stored dessicated
at -20°C. For assay a standard was reconstituted 
in 0 .2ml of bioassay medium and the insoluble material 
centrifuged off at 9 000 g for 5min.
Because of the tendency of Tyrodes phsiological- 
salts solution to lose CO2 and become alkaline on 
exposure to air, this was replaced by the HEPES- 
buffered medium described by Fujii and Miyashita 
(1975) for their experiments on guppy melanophores. 
Except where stated otherwise, this solution also 
contained 10’’^ M Rogitine (Phentolamine mesylate,
Ciba laboratories, Horsham, Sussex), 25mg 1~^ pkeriol- 
red as pH indicator, and 0.1% polypep (Sigma,low- 
viscosity type). (Polypep was used as a carrier, 
its osmotic contribution was ignored; Rogitine is 
an a-adrenergic antagonist and was included to 
guard against catecholamine-induced concentration 
of melanophores). Scales scraped from the dorsal
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surface of a freshly-killed black-adapted trout were 
immediately teased apart in this medium using 
dissecting needles under a binocular microscope.
From these scales, a sub-population was then selected 
for uniformity of appearance with regard to melanin 
content, dispersion and size. These were then 
placed in a seperate petri-dish so as not to overlap 
one-another, with their epidermal side uppermost.
These precautions were neccessary to minimize the 
spurious melanophore-concentration which occurs when 
scales are allowed to overlap. For assay, scales were 
taken at random from this sub-population.
For the detection of MCH activity, samples cannot 
usually be diluted sufficiently for the potentially 
toxic effects of solvents and the like to be ignored. 
For this reason, volatile buffers have been used 
throughout, and lyophilised samples reconstituted in 
bioassay medium for assay. For reconstitution, the 
amount of medium used was sufficient to buffer against 
acidic solutes as judged by the phenol-red indicator.
Because of the low peptide-content of fractions 
from HPLC, there was a danger that losses would 
occurr on lyophilisation of samples for bioassay.
Such samples were therefore supplemented with 1(^1 of 
a lOmg ml~^ solution of polypep befère lyophilisation.
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Lyophilisation, dilutions and assays were all 
performed in 96-well, flat-bottomed, tissue-culture 
plates of 0.35ml well-capacity (N° 76-001-05, Flow 
laboratories, Irvine, Scotland).
2 .6 Measurement of melanophore area
Because of the subjective nature of the MCH assay, 
and the variation between melanophore responses of 
different scales, minimal interpretation has been 
used in the assessment of such responses: scales 
being described as positive(+), threshold (+/-) 
or negative (-). This forfeits information which 
might otherwise be obtained were an objective 
means of assessment available. For this purpose a 
Vickers M-85A flying-spot microdensitometer was evaluated 
for objective measurement of melanophore responses.
The area of individual melanophores was measured. The 
instrument scans the field of view measuring density 
continuously within an area prescribed by an adjustable 
circular mask. The result obtained is an integrated 
value of the density within this area. The stark 
contrast between melanophore and background enabled 
adjustment of a density-threshold facility such that 
densities less than a chosen value were counted as 
zero. In this way, the integrated density measurement 
was of the melanophore alone and did not require 
subtraction of background. The density-threshold
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level was determined by measuring background density 
between concentrated melanophores - and increasing the 
threshold until the integrated density was reproducibly 
zero. The wavelength used was chosen as the Xmax of 
the difference-spectrum between background and 
melanophore - determined by point measurements without 
the use of integration or threshold facilities.
Instrument settings were : wavelength, 650nm; 
beam intensity 35; objective lens, 25X; density 
threshold 0.2; and scan time 2s. Measurements were 
made with scales epidermal side uppermost and immobilised 
in a cavity slide with a cover-slip.
Treatment of scales with experimental solutions 
was as for the MCH assay. Catecholamine solutions 
were made immediately before use.
2.7 Bioassay for MSH
In the absence of a homologous assay system whereby 
teleost MSH's might be assayed on teleost melanophores, 
the Anolis assay of Burgers (1961) was used according 
to the detailed description of Tilders et al (1975).
This assay is the same in principle as the MCH assay. 
Fragments of the skin of the lizard Anolis carolinensis 
are used to indicate the presence of MSH by a bright- 
green to brown colour change. Lizards were obtained 
from De Natuurvriend, Donkergaard, Utrecht, Netherlands.
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The assay was standardised by comparison to &-MSH, 
results being expressed as ^ g-equivalents of a-MSH.
The synthetic a-MSH standard used was the solution 
in 1% acetic-acid described under "radioimmunoassay of 
a-MSH". Not all assays were standardised in this way 
in which case results have been expressed in anolis 
units. The anolis unit is the same as the trout unit 
except that the basis of the unit is 1 .0ml instead 
of 0 .1ml.
Assays were performed in tissue-culture trays as for 
the MCH assay. Because of the greater dilutions 
involved, lyophilisation was generally unnecessary 
and samples were simply diluted. This was so, except 
when measuring sub-microgram amounts of MSH (i.e. when 
measuring MSH-contamination in highly purified 
preparations of MCH). In this case, where the MCH 
assay was to be conducted on the same fractions, 
reconstitution was performed in Anolis bioassay medium 
This was necessary to keep Rogitine out of the Anolis 
assay because it prevents response to MSH.
2.8 Radioimmunoassay for_d-MSH
The radioimmunoassay for a-MSH was developed by 
Mr. T. Bowley of this laboratory for the measurement 
of plasma MSH concentrations in trout. Its great 
sensitivity was not essential to this study and was 
sacrificed for increased range by increasing the 
concentrations of antiserum and radiolabelled MSH.
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The assay is essentially a hapten radioimmunoassay: 
antisera were raised against a conjugate of synthetic 
a-MSH (Sigma) and bovine serum albumin formed with 
ethyl carbodiimide (Thody et al 1975). The conjugate 
was administered to rabbits by intramuscular injection 
as an emulsion in Freunds complete adjuvant (DIFCO).
The particular antiserum used in this study is 
designated: R6 F B.
Radioiodination was performed using "chloramine T"
125according to Greenwood et al (1963); ImCi of I was
used to iodinate.-2pg of peptide. After iodination
the mixture was diluted with 30Cyal of assay buffer
and passed through a column of ODS-Spherisorb ( lO^ om
grade. Phase separations, Queensferry, Scotland).
The adsorbed peptide was eluted stepwise and the
fraction; eluting in 44% v/v methanol/1% TFA was
12 5taken. Radioiodinated a-MSH ( I-a-MSH) stored in 
this solution at -20°C was used for up to 3 weeks. 
Synthetic a-MSH (Sigma) was used as standard, amounts 
of 20yug— 20Qug were weighed accurately on a Cahn 
electrobalance and dissolved in 1% v/v acetic acid 
to a concentration of 200pg ml” .^ This solution was 
diluted-in assay buffer to 2^g ml”  ^and stored in 0.5ml 
lots in 1.5ml polypropylene centrifuge tubes at -20°C. 
Assay buffer consisted of 0.05M sodium phosphate pH 7.6 
containing 5% v/v inactivated horse-serum (Wellcome 
5) and 0.02% w/v ethyl mercuric thiosalicylate
Table 2
Crossreactivity of g-MSH antiserum R6FB with a variety 
of part-sequences of hACTH
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This data is unpublished work of Mr. T. Bowley of 
this laboratory. Cross-reactivity is expressed relative 
to that of a-MSH in molar terms. Synthetic peptides 
were a gift from Dr. W . Rittel of Ciba Laboratories, 
Basel, Switzerland. This antiserum appears to recognise 
the -Lys-Pro-Val-NH2 sequence at the C-terminal of 
a-MSH.
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("Thimerosal", Koch-Light). This solution was used 
as diluent for all samples and standards.
Incubation was at 4°C overnight in a volume of 40(^1
125containing 40 OOOcpm I-a-MSH and antiserum at a 
final dilution of 1/20 000. Bound and free label 
were then separated by adding 40(^1 of suspension of 
dextran-coated charcoal. After 15min, the suspension 
was centrifuged (4 600g, 15min, 4°C ) and the free 
counts present in the charcoal were determined after 
aspiration of the supernatant. The charcoal suspension 
contained; assay buffer, 70ml; inactivated horse-serum, 
30ml; charcoal (Sigma C/5260) 0.5g and dextran (Pharmacia 
T70), 0.125g. Charcoal was activated before use by 
heating to 200°C overnight. The suspension was stirred 
at 4°C for 30min before use.^
2.9 Radioimmunoassay for ACTH
The procedure for radioimmunoassay of ACTH was 
substantially the same as that for a-MSH except for 
the following:
The antiserum used was Wellcome*s anti-hACTH-serum 
RD 05 lot K7653 (Wellcome, Beckenham, Kent).
For standardization, Wellcome hACTH standard N°140872 
(2;-.43ng per vial) was used. The procedure used two 
separate incubations; the first, in 200/Jil of assay
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buffer contained antibody (at 1/20 000 dilution) and
sample, and was for 72h at 4°C; after addition of
125
IpACTH (9 800 counts in lOOyul) the mixture was 
incubated for a further 6-8h at 4°C and reaction was 
terminated by addition of dextran-coated charcoal as 
described by Rees et al (1971).
For radioiodination, porcine ACTH was used, this was 
supplied by the National Institute of Biological 
Standards, Hampstead, uondon code N° 69/22R. This 
preparation has been calibrated by NIBS in terms of 
the World Health Organization's third international 
standard pACTH, as containing 5. IDU per vial. The 
contents of a vial were dissolved in 125^1 of 0.005M 
HCl and stored in lOyul lots at -20°C. For iodination 
5pil (containing 2yug) was taken. The iodinated 
peptide was purified by adsorption onto QUSO G-32 
glass granules as described by Rees et al (1971).
Assay buffer was 0.05M sodium phosphate buffer pH7.4 
containing 2.5mg ml"^ bovine serum albumin (Sigma 
RIA grade) and 0.5% v/v 2-mercaptoethanol. (The 
mercaptoethanol is to minimise "incubation damage" 
which is a problem with ACTH (Yalow and Berson 1976)).
2 . 1 0  ODS-^  extract ion
Peptides in aqueous solution will adsorb strongly to 
hydrophobic surfaces such as octadecyl silanised silica
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(ODS-silica), from which they can be displaced by 
water-miscible organic solvents such as methanol and 
acetonitrile. This is the basis of the peptide- 
extraction technique of Kelly et al (197 8). Adaptations 
of this method have been used to extract peptides from 
crude extracts and to desalt phosphate-containing 
fractions from HPLC system 2.
For crude extracts in HCl or acetic acid, ODS-Porasil 
A was used. Porasil A (Waters Associates, Northwich, 
Cheshire) was reacted with octadecyl-trichlorosilane 
(CDS Koch-Light, Colnbrook, Berks.) as described by 
Bennet et al (1977). Columns were prepared by 
packing Porasil into 1 or 5ml Plastipak syringe 
barrels between discs of porous teflon (Waters).
Extracts were passed repeatedly through the column 
(nine times in all), after which the column was 
washed with 1% TFA (to remove non-adsorbed substances). 
Adsorbed peptides were then eluted with 80% methanol/
1% TFA. Loads up to 50mg of pituitary powder per ml 
of ODS-Porasil were applied and columns were discarded 
after use.
To desalt phosphate-containing HPLC fractions, 0.25ml 
columns of ODS-Spherisorb were used. To allow peptides 
to adsorb to the ODS, the acetonitrile concentration was 
reduced by diluting the fractions fivefold with 
deionised water. After a single passage of the sample 
through the column, it was washed with 0.5ml of deionised
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water and eluted with 2 X 0.5ml of 80% methanol/
1% TFA. After a 2ml water-wash, columns were re-used 
up to forty times.
-2.11 Gel-exclusion chromatography
Gel-exclusion chromatography (gel filtration) was 
performed using Bio-Gel P2 200-400 mesh (Bio-Rad 
Laboratories, Watford) and Sephadex G-25 fine (supplied 
by Sigma, Poole, Dorset). Columns were eluted with 
and samples were applied in - IM acetic acid (pH 2.4).
The absorbance of the effluent was monitored continuously 
at 280nm using an ISCO model UA 5 spectrophotometer 
with a type 6 optical unit fitted with 0.5cm path- 
length flowcells (supplied by Fis ons of Loughborough).
2.12 Two-dimensional cellulose thin-layer electro- 
phores i s/chromatography
For analytical purposes this technique was carried out 
according to Heilan# et al (1976) using Merck glass- 
backed cellulose TLC plates of 0.1mm layer thickness 
(product number 5716, supplied by BDH, Poole).
Where larger sample loads were used the two methods 
were performed separately and sample was applied to the 
dry plate as a 5cm band. In electrophoresis, the sample 
was applied first (methyl-green was applied in a 
seperate spot as a reference) and the plate was sprayed 
with solvent. The solvent-system for electrophoresis 
was; pyridine, glacial acetic acid, acetone and water
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in the ratios 1:2:8:40 v/v respsctively pH4.4.
That for chromatography was: n-butanol, acetic acid, 
pyridine, and water in the ratios 15:3:10:12 v/v 
respectively. Plates were air dried and the seperated 
peptides were visualised by spraying with a 0 .01% 
w/v solution of fluorescamine (Sigma) in acetone/ 
pyridine 9:1 v/v. Where bioassays were to be performed 
the plate was scraped in 5mm bands and peptides were 
eluted with 3 XlOO^l of 50% v/v acetic acid. This 
was achieved by transferring the resulting powder 
to a syringe-barrel tightly plugged with porous 
teflon, and washing the powder by successive vortexing 
and centrifugation (at 2 OOOg for 2mins) with the 





1 ml syringe barrel (Plasipak)
radioimmunoassay tube for 
collection of eluant (Sarstedt 
N° 55.478)
Fig 2 Apparatus for eluting TLC fractions shown before 
centrifugation.
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2 .13 Ion-exchange chromatography
The cation-exchanger SP-Sephadex C-25 (sulpho-propyl 
Sephadex, supplied by Sigma) was converted to the 
ammonium form by repeated washing and décantation in 
IM ammonium acetate pH7. After equilibration with 0.05M 
ammonium acetate pH4.8 containing 20% v/v methanol 
(starting buffer), a column was packed to give a bed 
of dimensions: 30 X 2.5cm. Samples were prepared 
by dissolving lyophilized extracts in starting buffer 
and centrifuging off that which remained insoluble" 
at 90 OOOg for 30min. The supernatant was applied 
to the column followed by 2 00ml of starting buffer 
to elute those substances not bound to the exchanger 
under these conditions. This was followed by an 800ml 
gradient of ammonium acetate of increasing concentration 
and pH at constant methanol concentration (20% v/v).
The gradient was from 0.05M pH4.8 to l.OM pH7.0 and 
was linear with respect to concentration. Eluate 
absorbance was monitored as for gel-filtration.
2 ,14 High-performance liquid chroamtography (^HPLC )
Two HPLC systems were used: the first was 
that of Bennet ^  ^  (1977) and used prepacked
analytical-scale columns (250 X 4.6 mm) or seml^ 
preparative scale columns packed in the laboratory 
(300 X 8 mm) containing Partisil-lO-ODS (irregularly 
shaped octadecyl-silanised silica of 10pm particle-
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size supplied by Whatman,Maidstone, Kent). Columns were 
slurry packed by upward flow from methanol. HPLC 
accessories were obtained from HSTP of Macclesfield, 
Cheshire. Columns were eluted with linear gradients of 
increasing methanol concentration in 1% v/v TFA generated 
at low pressure using syphon-linked beakers,and were 
delivered by a single Milton-Roy instrument mini-pump.
The absorbance of the eluate was monitored continuously 
at 280nm using an LKB Uvicord II spectrophotometer 
with %a 2cm path-length micro flow cell. As the solvents 
used were completely volatile, peptides could be 
recovered by evaporation under reduced pressure.
Samples dissolved in the primary solvent (1% TFA) were 
applied to the column through the pump.
The second HPLC system was a purpose built apparatus 
manufactured by Altex, supplied by Anachem of Luton. 
Gradient formation was microprocessor controlled via 
models 100 and 110 solvent metering pumps. U.V. detection 
was at 225nm using a Pye-Unicam variable wavelength 
spectrophotometer with a 1 0 X 1mm, ^ 1  flowcell.
Tripartite linear gradients of increasing acetonitrile 
concentration in 0.2M phosphate buffer pH 2.1 were 
applied to laboratory-packed analytical scale columns 
(150 X 5mm) of Nucleosil-5-ODS (Macherey-Nagel, Duren, 
G.F.R.) or Hypersil-ODS (Shahdon, Runcorn, Cheshire).
The buffer was 0.lMNaH2P0^ brought to pH 2.1 with
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H^P04 (total phosphate concentration 0.2M). The 
secondary solvent was 60% v/v acetonitrile in this 
buffer. This method is basically that of O'Hare and 
Nice (1979). Samples were applied through a high- 
pressure injection- valve fitted with a 2ml sample 
loop. The greater U.V. transparency of the acetonitrile/ 
phosphate system enabled the use of a shorter wave­
length for the detection of peptides regardless of 
whether they contained tryptophan.
2.15 Fluorometric determination of tryptophan content 
of peptides
Detection and measurement of the tryptophan fluorophor 
was achieved by obtaining emission spectra of peptide 
samples excited at 2 80nm in 80% methanol/1% TFA. Slit 
widths were : excitation, 2mm; emission, 0.5mm - this 
was a useful compromise between sensitivity and 
resolution.
All fluorescence measurements were performed in an 
Aminco SPF 125 spectrophotometer with a 1cm quartz 
cuvette containing 1 .0ml of sample.
2.16 Amino-acid analysis
Amino-acid analysis was performed on acid hydrolysates 
of peptide samples using an amino-acid autoanalyser 
and also by a highly sensitive manual isotopic method 
using dansyl chloride. Hydrolyses were performed with
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100^1 of Aristar 6M HCl (BDH, Poole), 0.5ml/l 2-mercapto- 
ethanol (Sigma type I) in sealed, evacuated Pyrex tubes 
(75 X 10mm, No 1622 302) at 105° for 16h. Sometimes 
3M mercaptoethane.sulphonic acid (MESNA, Pierce 
Sequanal grade) was used for the estimation of tryptophan 
as well as all of the other amino-acids. After 
hydrolysis for 24h in 100/ul of MESNA, samples were 
neutralised to pH=d.2 and diluted by addition of 1.4ml 
of 0.15 M NaOH. 30Gyul samples of the resulting 
solution were pumped directly onto the autoanalyser 
column. (This is a micro-version of the method of 
Penke et al, 1974). All glassware was cleaned by 
conventional means followed by "ignition cleaning" by 
treatment at 500°C overnight in a muffle furnace. Care 
was taken to avoid contamination from fingerprints 
and dust.
The amino-acid autoanalyser was a Chromospek by Rank
Hilger of Margate, Kent. Calibration of both methods
was performed with Calbiochem's AA5 amino-acid mixed
standard (Calbiochem, Bishops Stortford, Herts). The
manual method used was that of Brown and Perham (1973).
This technique uses ^^C-amino-acid internal standards
and ^H-dansyl chloride (^H-Dns Cl). Samples of ^^C
amino-acid mixture and of peptide hydrolysate are mixed
3and allowed to react with H -DnsCl. The resulting 
Dns-derivatives are separated by two-dimensional 
TLC on polyamide plates, and the ^H/^^C ratio for
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each is then then determined by liquid scintillation 
counting. For a given Dns-amino-acid, the ratio
is proportional to the amount of unlabelled amino-acid 
present in the hydrolysate. The method is first 
calibrated using the AA5 mixture and thereafter standard- 
curves are used to convert ratios to pmoles
of amino-acid.
Radiochemicals were obtained from the Radiochemical
Centre, Amersham. Supplementation of the ^^C amino-
acid standard mixture with ^^C-histidine was unnecessary
as this is how included by the manufacturers. The
commercially available scintillant Unisolve 1 (BDH)
was found to be a suitable substitute for that used
by the original authors. Channels were set on the
scintillation counter for use with this scintillant such
3that effectively no H counts (<1%) appeared in the 
"^^ C channel, and 35% of ^^C counts appeared in the
3
H channel. The fragments of TLC plate were not 
r e m o v e d  f r o m  the vials before counting but this did 
not interfere. Schleicher and Schull two-sided 
micropolyamide TLC plates (F1700) were obtained from 
Pierce and Warriner (UK) of Chester.
2.17 MCH stability experiments
An extract of 250mg of acetone-dried pituitary powder 
was prepared in 5ml of IM acetic-acid at room temperature 
Lyophilised or ODS-extracted samples of this extract
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were used for the following treatments.
a) TPCK-Trypsin digestion
A lyophilised 1ml sample of the acetic acid extract 
was reconstituted in 1ml of bioassay saline. To 
100^1 aliquots of this solution, 900yul samples of 
each of the following fresh solutions was added:
(i) TPCK-trypsin 200^g ml~^ (trypsin digest)
(ii) TPCK-trypsin 200pg ml“  ^ containing 500^g ml~^
ovomucoid trypsin inhibitor (control for
the non-enzymic effects of added trypsin).
( iii): ' Ovomucoid trypsin inhibitor 500yUg ml ^
(control for the non-specific effects of
added trypsin inhibitor)
(ivj Saline alone (control for autodigestion
by endogenous protease).
After 2h at 37°C reaction was stopped by addition of
trypsin inhibitor (1ml containing 500yug) . Trypsin was
Sigma type XI1 N° T 2884; to ensure freedom from
chymotryptic activity it was first treated with
L-l-tosylamide-2-phenylethyl chloromethyl ketone
(TPCK) according to Carpenter (1967). Trypsin
inhibitor was Sigma type III-O N° T 2011 ovomucoid
trypsin inhibitor.
b) Pepsin digestion
To lOOyUl of acetic acid extract, 400yul of a fresh
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solution of pepsin ( lOOyug ml  ^in 1.5% v/v formic acid)
was added. As a control, half of this solution was
immediately heated to 90°C for 5min to denature the
enzyme; the other half was incubated at 37°C for 2h and
then denatured. Both samples were then frozen, lyophilised, 
and reconstituted in bioassay medium. Pepsin.(EC 3.4.23.1) 
was Sigma N°P7012.
c) Cyanogen bromide treatment
To lOOpl of crude extract, an equal volume of a 5mg ml  ^
solution of cyanogen bromide in 90% v/v formic acid 
was added. Samples were incubated at 40°C for 2h. 
Non-peptide reaction products (except Br") were 
removed by lyophilisation. A reagent blank was prepared 
using lOOyul of IM acetic acid instead of extract.
After lyophilisation, lOOyul of extract was added to 
the blank which was again lyophilised; this served as 
a reagent-blank control for the potentially toxic 
effects of non-volatile reaction-products.
d) Hydrogen peroxide oxidation
The procedure of Neumann (1972) for the residue-specific 
oxidation of the methionine residues of ribonuclease 
was adapted as follows. For this treatment, the sample 
must be free of halide ions and organic acids because 
of their tendency to form free atoms and organic 
-peracids in the presence of hydrogen peroxide. A 1ml
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sample of the acetic acid extract was therefore 
extracted by repeated passage through a 2ml column 
of ODS-Porasil packed in a 5ml syringe barrel, after 
washing with water, the adsorbed peptides were eluted 
with 80% v/v methanol (without TFA). TheJdried residue 
of the aqueous methanol eluate was reconstituted 
in 2ml of distilled water and half of the sample 
was oxidised by addition of 3CJul of 30% v/v hydrogen 
peroxide and incubated at 37°C for 2h (the other half 
was incubated without hydrogen peroxide as control). 
Remaining peroxide was removed before bioassay by 
dropwise addition to 40(Jul of a solution of catalase 
(Sigma, thymol-free N°C40) at Img ml  ^ in O.OIM phosphate 
buffer pH7.0. The MCH activity of the untreated 
half was compared to that of the oxidised sample and 
to an oxidised sample which had been reduced with 
thioglycollic acid.
e) Thioglycollic acid reduction
To lOOyul samples of crude acetic acid extract and 
H 2 0 2-oxidised extract, 400^1 of a 0.5% v/v solution of 
thioglycollic acid in distilled water was added. Tubes 
were flushed with nitrogen, sealed, and incubated at 
50°C for 5h.
f) Mild alkali treatment
A lyophilised sample of lOOyUl of crude extract was
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reconstituted in 500yul of IM ammonium acetate buffer 
pH 10.5. This was incubated at 37°C for 2h. Reaction 
was stopped by freezing and lyophilisation. This 
procedure was designed to test stability to alkali 
without causing racemization.
2.18 Reagents and solvents
Except where specified otherwise reagents and solvents 
were analytical reagent grade. For HPLC, methanol and 
acetonitrile were HPLC grade (Rathburn Chemicals, 
Walkerburn) or Spectrograde (Fisons, Loughborough) 
and aqueous solvents were filtered by passage through 
a 50 X 8mm column of Partisil 10 CDS. For spectro- 
fluorometry, acetone and methanol were spectrograde 
and aqueous solvents were filtered using Millipore 
0 .2yam filters.
2.19 Fast-atom bombardment mass-spectrometry of peptides
Mass-spectral analysis of peptides was performed by Ms. 
C. V. Bradley of the University Chemical Laboratory, 
Cambridge. Mass-spectra were obtained on a Kratos 
MS 50 instrument ôperated at accelerating voltages 
from 5 - 8kV. Samples were introduced to the ion- 
sour ce on a copper probe tip via a conventional vacuum 
lock. Peptide samples dissolved in a small quantity 
of glycerol were applied to the probe-tip as a thin 
film. The area of the tip was 0.1 - 0.25cm? and 
typically 10 - 50% of this was covered with the glycerol
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solution.
Ions from the sample weis obtained in the gaseous 
phase by bombardment of the glycerol solution with 
Air atoms at 4 - 6 keV at a pressure of about 10~^ torr. 
These atoms were obtained by charge-exchange with 4 - 6  
keV Ar ions, using a standard fast-atom bombardment 
source and associated fast-atom gun (Kratos, Urmston, 
Manchester). Spectra were scanned from high to low 




3.1 The effect of various chemical and enzymatic 
treatments on the activity of MCH
Introduction
A variety of factors were investigated for their 
effect on the activity of MCH in an attempt to gain 
information on its chemical nature. For thesec ;experimehts 
a crude unheated extract of 250mg of acetone-dried 
pituitary powder was used. Samples of this were taken 
for each treatment - the activity of experimental 
samples being measured relative to appropriate reagent 
blank controls (see section 2.17).
a) Trypsin
TPCK-trypsin caused a drastic reduction in MCH 
activity (Table 3)• This effect was prevented by 
excess trypsin-inhibitor and was therefore due to 
the enzymic action of trypsin and was not a non­
specific effect of added protein.
Most preparations of trypsin contain a small amount 
of chymotrypsin, and unless this is removed, the 
action of chymotrypsin can be erroneously attributed 
to trypsin. In this way substance P was once falsely 
identified as being trypsin-sensitive (see Leeman et al 
1977). For this reason TPCK treated trypsin was used.
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Table 3 The effect of various chemical treatments on 









hydrogen peroxide oxidation 
followed by thioglycollate 
reduction
1/2
mild alkali (pH 10.5) 1
* In each case, appropriate reagent-blank controls 
wereincubated in parallel with the experimental samples 
(see section 2.17). Two-fold dilution series of experi­
mental and control samples were compared within the same 
assay.
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(TPCK is an active-site directed irreversible inhibitor 
of chymotrypsin; TPCK-trypsin was prepared according 
to Carpenter (1957)).
Since trypsin is very specific for peptide bonds on 
the C-terminal side of Arg or Lys residues, we can 
infer that MCH is a peptide containing either or both 
of these residues. Furthermore, we know that if MCH 
contains only a single Lys or Arg, this can not be 
situated at the C-terminal. The existence of Arg 
and /or Lys in the peptide may explain its cationic 
behaviour during electrophoresis and ion-exchange 
chromatography.
b) Pepsin
Although pepsin prefers to cleave peptide bonds on 
the C-terminal side of aromatic residues (Trp,
Phe, Tyr), its specificity is rather broad and 
it will cleave most peptides to small oligopeptides 
eventually. It was unexpected therefore to find that 
treatment with pepsin caused a 15-fold enhancement 
in MCH activity (Table 3). Perhaps this represents 
liberation of MCH from a precursor in the pituitary 
extract by limited proteolysis. Conversely, this 
could be caused by destruction of an inhibitor.
However, although there appears to be an inhibitor in 
the hypothalamus - this is not so for the pituitary 
(section 3.9).
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C ) Cyanogen bromide
Treatment with cyanogen bromide will cleave peptide 
bonds on the C-terminal side of methionine residues.
This was found to reduce MCH activity to 1/8 of the 
control value (Table 3). The great excess of this 
reagent used (in molar terms) would suggest that 
partial inactivation was not due to incomplete 
progress of the cleavage reaction. These results 
would suggest that MCH undergoes cleavage with cyanogen 
bromide to form products of lower biological activity 
than the intact peptide, which would infer the 
existence of a methionine residue in MCH.
d) Oxidation with hydrogen peroxide
Oxidation with hydrogen peroxide, which was designed 
to oxidise methionine residues to the sulphoxides 
(section 2.17d) was found to cause about a 2-fold 
enhancement in MCH activity (Table 3 ). The significance 
of such a small difference is questionable in view 
of the poor precision of the MCH bioassay. However, 
that this finding is significant -is indicated by 
the observation that subsequent reduction with thio­
glycollate caused a fourfold reduction in MCH activity, 
whilst thioglycollate reduction of non-oxidised 
samples was without effect.
Generally, methionine sulphoxide derivatives of 
biologically active peptides are less active than
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their native counterparts and it would appear that 
MCH is exceptional in this respect.
e) Reduction with thioglycollate
Reduction with thioglycollate had no apparent effect 
on the activity of MCH. Since this treatment will 
break disulphide bridges yielding separate cysteine 
residues; either MCH does not contain a disulphide 
bridge, or if it does - then this is not essential 
to its biological activity.
f) Oxidation with hydrogeiperoxide followed by reduction 
with thioglycollate
Since treatment with thioglycollate will reverse the 
effect of peroxide-oxidation on methionine residues 
(i.e. will regenerate methionine side-chains from 
methionine-sulphoxide side-chains); were the effect of 
peroxide-oxidation on MCH due to oxidation of 
methionine, then this should be reversed by subsequent 
reduction with thioglycollate. To investigate this, 
an aliquot of the sample which had been oxidised 
with hydrogen peroxide was reduced with thioglycollate. 
The net effect of these two treatments was to reduce 
MCH activity to about half that of the control 
value (Table 3).
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Because of the dubious significance of such a small 
difference, this observation is consistent with the 
hypothesis that the peroxide induced enhancement in 
the biological activity of MCH was via oxidation of 
methionine residues,
g) Treatment with mild alkali (pH 10.5)
Rudman et al (1979) have shown that mild alkali 
(pH 10.5) will remove the 0-acetyl group of diacetyl- 
serine-a-MSH converting it to a-MSH. Tq see if 
MCH contained an alkali-labile group such as this, 
its stability was tested in IM ammonium acetate 
buffer pH 10.5. After incubation at 37°C for 2h 
there was no detectable change in MCH activity.
3.2 Evaluation of chromatographic methods for 
the purification of MCH
Introduction
The original aim of this project was the isolation 
of MCH. This has not previously been attempted and 
it was necessary therefore to evaluate methods which 
might be used preparatively to isolate MCH. The main 
criterion used to evaluate methods was their ability 
to seperate MCH from MSH. Ihis was considered 
important since Kent (1961) had hypothesized that 
teleost pitùitaries contained a single factor which was 
responsible for both biological activities.
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a) Gel-filtration
When extracts of fresh trout-pituitaries were subjected 
to gel-filtration on Biogel P2, peaks of MCH and MSH 
bio activity were found which were sufficiently 
separate to indicate that the factors responsible for 
concentration of trout melanophores and dispersion of 
Anolis melanophores were different (Fig 3). Since 
both eluted after the void volume (Vo), this suggested 
that they were less than 1800 daltons (the nominal 
exclusion-limit of this gel). Fig 3 also shows clearly 
that MCH is not a catecholamine since its elution 
position differs greatly from that of dopamine.
b) HPLC of crude extracts
HPLC of extracts of fresh pitùitaries resolved MCH into 
two peaks but only achieved partial separation from 
MSH which also was resolved into multiple peaks (Fig 4). 
The existence of two types of MCH is confirmed by 
the results of ion-exchange chromatography (section 
3.3) .
c) ODS-extraction
Since MCH was reversibly retained by ODS-silica 
during HPLC, it was considered that ODS-extraction 
(Kelly et al, 1978) might be used as a first step in the 
purification of MCH. Indeed, Kelly et àl hâve shown 
that peptides can be extracted in this way from acid
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extracts in high yield. Because MCH is difficult to
quantify (see section 3.5), to monitor recovery 
125I-a-MSH was used as an internal standard; this 
was justified by its similar elution position to 
MCH in HPLC on ODS-silica. Fig 5 shows how repeated 
passage of an acid extract of pituitary powder through 
a column of ODS-Porasil resulted in progressive 
accumulation of label by the column. Altogether 
70% of the label was accumulated by the column, of 
which 99% was afterwards eluted in a single wash with 
0.5ml of 80% methanol / 1% TFA. The load used was 
deliberately high (an extract of lOmg of pituitary 
powder per 0.4ml bed-volume) and failure of the label 
to adsorb readily or completely to the ODS-Porasil 
may indicate that its capacity was exceeded. Later 
it was realized that at least gram quantities of 
pituitary powder would be needed to purify MCH. This 
would require amounts of ODS-Porasil so large as to 
be impracticable at this stage of purification and 
the procedure was not adopted as the first purification 
step.
d) Thin-layer methods
Although MCH can be recovered from PAGE on an analytical 
scale, this is not a good preparative method. In 
contrast, thin-layer methods are often used for 
peptide purification and recovery of peptides is 
facilitated by the use of volatile buffers.
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During thin-layer electrophoresis and thin-layer 
chromatography MCH migrated as a single peak (Fig 6 ). 
Having established that MCH could be recovered from 
these techniques, they were then evaluated for their 
ability to separate MSH and MCH. Fig 7 shows the 
two methods performed successively on the ODS-Porasil 
extract of Fig 5. Clearly these methods were ineffective 
at separating MCH and MSH.
Baker and Ball (1975) were able to separate MCH from the 
a-MSH*s of trout pituitary by polyacrylamide gel 
electrophoresis (PAGE). The greater effectiveness 
of PAGE was probably attributable to the molecular 
sieving properties of the gel since the pH of both 
thin-layer electrophoresis and PAGE were similar 
(pH 4.4 and pH range 3.8 - 4.4 respectively).
125The recovery of I-a-MSH internal standard after
ODS-extraction and thin-layer electrophoresis / 
chromatography is given in Table 4. Recovery of 
this label was particularly low from TLC, This was 
probably because at this stage of purification the 
label was essentially free of carrier peptides, since 
visualization with fluorescamine showed no peptide 
spots in the region of the chromatogram from which 
radiolabel was recovered. i.e. These results do not 
necessarily indicate that recovery from thin-layer 

































d p H  












Fip. 3 Gel-filtration of an ODS-Porasil extract of 
trout pitùitaries on Bio-gel P2 (exclusion limit 1800 
daltons). An extract of 70 pitùitaries was prepared 
by sonication in 3.0ml of 0.IM HCl. After centrifugation 
the supernatant was passed through a 0.4ml column of CDS 
Porasil. Adsorbed solutes were eluted with 0.5ml of 80% 
methanol / 1% TFA and this solution was evaporated to 
dryness under partial vacuum. The residue was reconsti­
tuted in 300 yul of IM acetic acid and applied to a 70 X 
1.1 cm column of Bio-gel P2 eluted at 7 ml min  ^ in the 
same solvent. Fractions of 1.0 ml were collected and 
bioassayed for MCH and MSH. The elution positions of 
BSA and dopamine - denoted by the absorbance trace - 
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Ficf. 4 HPLC (system 1) of an ODS-Porasil extract of 70 
fresh trout pitùitaries. The extract was prepared as for 
Fig. 3. The dried residue was reconstituted in 2ml of 1 %  
TFA and applied to a 250 X 4 mm column of Partisil-10-ODS 
operated at a flowrate of 1.0 ml min ^. This was followed 
by a simple linear 178ml gradient from 20-80% methanol. 
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Fig 5 An extract of 20mg. of acetone-dried pituitary
powder was prepared in 1.0ml of 0.IM HCl by sonication
at room-temperature. After centrifugation,12 000 cpm. 
125of I-a-MSH (about 25pg) was added to the supernatant 
which was passed repeatedly through a column of ODS- 
Porasil (0.4ml bed-volume). At each step the amount 
of radiolabel which had adsorbed to the ODS-Porasil 
was determined by counting both the eluate and the 
column.
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Fig. 6 An extract of ten trout pitùitaries was prepared 
in electrophoresis buffer. After centrifugation,half the 
supernatant was applied as a 5cm band to each of two 
cellulose TLC plates. One was subjected to electrophoresis 
- the other to chromatography. The plates were scraped 
in 5mm bands and these fractions were eluted, lyophilized 
and bioassayed for MCH.
Fig .7 The ODS-Porasil extract described in Fig .5
was subjected to electrophoresis then chromatography
on cellulose thin-layers. In each case bioassays were
performed for MSH and MCH. In a separate track, a-MSH
was run as reference standard - its position was
125visualized by spraying with fluorescamine. ' I-a-MSH
was present as internal standard and its recovery from 
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Table 4
126Recovery of I g-MSH after ODS-extraction and
electrophoresis / chromatography on thin-layers
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125The recovery of I-a-MSH was monitored throughout 
purification as a guide to the recovery of MCH and 
MSH.
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e ) Affinity chromatography with Concanavalin A
Concanavalin A (Con A) is a phytohaemagglutinin 
which will bind saccharides and polysaccharides 
bearing non-reducing terminal a-D-mannopyranoside 
or g-D-glucopyranoside residues. (For a review of 
the properties of this metalloprotein see Sharon and Lis 
(1972)). Glycoproteins or glycopeptides satisfying 
these criteria will also bind to Con A (e.g. pro- 
opiocortin,Kfieger and Liotta, 1979) . Were MCH 
to bind to Con A, this would prove a valuable tool in 
its purification. To determine this, an extract of 
lOmg of acetone-dried pituitary powder was prepared by 
sonication in 1.0ml of 0.IM ammonium acetate buffer 
pH 5.6 and applied to a 1.0ml column of Con A-Sepharose 
4B. The column was then eluted at a flowrate of 3ml h  ^
with 5ml each of: buffer, a-methyl-D-mannopyranoside 
0.5M in buffer, and finally with 66% v/v acetic acid.
The acetic-acid was used to elute non-specifically 
bound substances. One ml fractions were collected and 
lyophilised. For reconstitution, sugar-containing 
fractions were made-up in 2.5ml of distilled water 
and diluted with MCH-bioassay medium 
for assay. Other fractions were reconstituted 
directly in bioassay medium.
The only fractions to contain MCH activity were the 
first two of the initial buffer wash showing that MCH 
was not retarded or bound by Con A. In view of the
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high specificity of Con A, failure of MCH to bind 
to it does not exclude the possibility that MCH is a 
glycopeptide.
f) Ion:exchange chromatography
The cationic behaviour of MCH and MSH during electro­
phoresis suggested that cation-exchange chromatography 
might be used to seperate them. At low pH and low 
ionic strength (pH 4.8, 0.05M ammonium acetate) both 
bioactivities were bound by the cation exchanger 
SP-Sephadex C-25. In a pilot experiment a gradient 
from 0.05M ammonium acetate pH4.8 to 0.5M pH 7.0 
was found to elute MCH and MSH bioactivity rather late 
in the gradient suggesting that there might be other 
peaks which remained irreversibly bound to the 
exchanger under these conditions. This was indeed 
found to be so since gradients to l.OM pH 7.0 eluted 
further peaks of MSH bioactivity. The results of 
ion-exchange chromatography under these conditions are 
described fully in the next section.
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3.3 Preparative ion exchange chromatography
Fig 8 shows the results of ion-exchange chromatography 
of crude acetic-acid extracts of both of the commercial 
salmon pituitary powders using gradients of ammonium 
acetate from 0.05M pH 4.8 to l.OM pH 7.0. Good 
separation of MCH and MSH was obtained, and this 
method was also able to tolerate high sample loads 
(gram quantities). It was therefore used as the first 
chromatographic step for purification of MCH,
As in HPLC (Fig 4), ion-exchange separated MCH into 
two peaks (Fig 8 ); however, the elution positions 
of these peaks differed when extraction was performed at 
100°C (b,c) instead of at room temperature (a). 
Subsequent analysis (section 3.6a) indicated the 
presence of N-terminally shortened forms of des- 
acetyl-a-MSH in the unheated extract (a). For this 
reason extraction with heat was adopted routinely 
to preclude proteolysis in the extracts. A further 
advantage of using heated extracts,evident from Fig 8 
is the superior separation of MCH and MSH which was 
obtained.
In all cases, two peaks of a-MSH immunoreactivity 
were found. On the basis of their elution order, the 
first less basic peak was tentatively identified as 
a-MSH and the other as desacetyl-a-MSH.
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In the case of the heated extracts (b,c) "a-MSH" 
coincided with a shoulder of the major peak of MSH 
bioactivity indicating the presence of another MSH; 
possibly a type of ^-MSH. This MSH comprised most of 
the Anolis melanophore-dispersing activity of the 
extracts.
In the lyophilised pituitaries (c) there was a marked 
preponderance of the desacetyl form of a-MSH. The 
significance of this is uncertain, but it is interesting 
that acétylation can enhance by 10-fold the biological 
potency of desacetyl-a-MSH in both the Anolis and 
frog bioassays (Ramachandra-n and Li (1967), frog;
Mr. T. Bowley (personal communication), Anolis).
For further purification of MCH, the first MCH 
peaks of Fig 7a and c have been used; note that these 
appear to be different peptides. Peptides from Fig 7b 
were not subjected to further purification, this run 
was used only to check the reproducibility of the 
method.
Fig.8
Cation exchange chromatography of salmon MSH and MCH; 
the effect of heating the extracts . Extracts of the 
commercial pituitary powders in IM acetic acid were 
lyophilized and reconstituted in 70ml of starting buffer 
using a homogeniser. The resulting suspension was 
centrifuged at 90,000g for 30min and the supernatant 
was applied to a 30 x 2.5 cm column of SP-Sephadex 
C-25 equilibrated in the same buffer and run at a 
flowrate of 40ml h ^ . After application of the 
sample, the column was washed with a further 200ml 
of starting buffer to elute non-absorbed solutes.
This was followed by an 800ml linear concentration- 
gradient of ammonium acetate (from 0.05M pH 4.8 to 
l.OM pH 7.0). No MSH or MCH bioactivity could be 
detected in the initial 200ml wash, and only the 
fractions collected after application of the gradient 
are shown. In peptides purified from a, there was 
evidence that proteolysis had occurred. In an 
effort to avoid this, extraction was subsequently 
performed in boiling acetic acid (in b and c).
Stippled histogram = MCH . The MCH bioassay was : 
performed semi-quantitatively - enough to identify 








































































elution volume in ml
66
3.4 Partial purification of MCH
a) Purification of MCH from acetone-dried pituitaries
This purification is summarized in the flow diagram 
(Fig 9).
Two peaks of MCH bioactivity were recovered from ion- 
exchange chromatography of a crude acetic-acid extract 
of acetone-dried pituitaries (Fig 8a). The first 
peak was taken for further purification because it 
contained most of the MCH bioactivity and was relatively 
free of MSH bioactivity and a-MSH immunoreactivity.
The fractions comprising this peak were pooled, 
lyophilised and reconstituted in IM acetic acid. The 
acetic acid solution was then subjected to gel-filtration 
on a column of Sephadex-G-25 eluted in the same solvent 
(Fig 10). A single peak of MCH bioactivity was recovered 
which did not correspond to any peak in the absorbance 
trace. Its elution position suggested that it was 
intermediate in size between the synthetic peptides : 
desacetyl-a-MSH (1523 daltons) and hACTH 1-24 (2934 
daltons). This is consistent with earlier findings 
from chromatography of crude extracts on Bio-Gel P2 
(section 3.2a) and with subsequent estimates from 
Sephadex G-25 (section 3.10) which suggest a molecular 
weight of 1700 daltons.
The MCH bioactive fractions from gel-filtration 
(Fig 10) were pooled in a siliconized borosilicate-
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glass vial and stored frozen at -20°C. This solution 
was applied directly to a semi-preparative scale HPLC 
column (HPLC system 1) which was eluted with a 
gradient of methanol in 1 %  TFA (Fig 11). Since 
peptides from gel-filtration in IM acetic-acid were 
found to concentrate on the HPLC column, this obviated 
the need for concentration by lyophilisation. Both MCH 
and MSH bioassays were performed on the resulting 
fractions. It was evident from the absorbance trace 
(Fig 11) that useful purification from non-bioactive 
peptides had been obtained, however, this method 
was only partly effective at purifying MCH from 
residual contaminating bioactive MSH (for a quantitative 
comparison see Table 5).
The MCH-containing fractions from this HPLC run were 
pooled, and to allow application to HPLC system 2, 
the methanol concentration was reduced by evaporation 
under reduced pressure until the sample was 1/5 its 
original volume. In later purifications it was found 
to be sufficient to reduce the concentration of 
organic modifier (acetonitrile or methanol) by 
dilution with an equal volume of deionised water.
Aliquots of the concentrated sample were then applied 
to HPLC system 2 - an analytical-scale column of 
Nucleosil-5-ODS eluted with gradients of acetonitrile 
in acid phosphate buffer. First, to establish what 
sort of gradient would best resolve all peptide
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components of the sample, small aliquots were 
sacrificed in analytical runs - modifying the 
gradient each time to optimise separation (not shown).
Under the conditions thus established, 1/10 of the 
sample was then chromatographed and bioassays were 
performed for MCH and MSH (Fig 12a). MCH was found 
to co-elute with a peak of MSH bioactivity. Even at 
this stage of purification, MCH still did not correspond 
to an absorbance peak. Previously, at 280nm, this 
could have been due to absence of tryptophan in 
the peptide, but all peptides absorb at 225nm - 
the wavelength used here.
A further aliquot of 1/10 of the sample was then 
chromatographed with a slightly modified gradient 
to try to improve resolution in the region where 
MCH eluted (Fig 12b). This achieved some separation 
from contaminating MSH bio activity but was unsuccessful 
at isolating MCH.
The remainder (65%) of the sample (after ion-exchange, 
gel-filtration and HPLC system 1) was committed to 
chromatography under the conditions of Fig 12b and 
the MCH-containing fractions were collected, diluted 
1:1 with water and reapplied to the same column.
This served to reduce the peptide content of the 
sample optimising sample-load for re-chromatography.
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For re-chromatography on HPLC system 2, rather than 
eluting with a gradient, the column was eluted with 
a constant concentration of 17% acetonitrile 0.06M 
phosphate buffer pH 2.1 (isocratic elution ). Bioassay 
showed that MCH eluted after 39min under these conditions 
but the resulting peaks were so dilute as to be 
undetectable by their absorbance. Since the absorbance 
trace could not be used to assess purity, N-terminal 
determinations and amino-acid analyses were performed 
on this MCH preparation.
Before such analyses could be performed it was 
necessary first to desalt the peptide preparation.
This was achieved by ODS-extraction (see methods), 
salt-free peptides were recovered from the resulting 
solution in 80% methanol 1%.TFA by evaporation to 
dryness under reduced pressure.
N-terminal determinations by the dansyl method showed 
the MCH preparation to be heterogeneous : N-terminal 
Asp and Lys were found together with internal Lys and 
Tyr. Amino-acid analyses by the dual-isotope 
method confirmed the presence of these residues and 
that the preparation was heterogeneous since non­
integral ratios were found. Because the preparation 
was impure, none of these findings necessarily 
pertain to MCH wich could still be a minor component 
of the preparation.
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Solvent blanks prepared in parallel with the MCH 
sample by drying samples of 80% methanol 1% TFA 
were found to contain undetectable levels of amino- 
acids in both the N-terminal and the amino-acid 
analyses.
No further purification was obtained by re-chromatography 
on HPLC system 2 under isocratic elution as judged 
by the specific activity (i.e.bioactivity per unit 
mass) of the peptide preparation obtained.
Overall purification and yield
In the purest preparation of MCH obtained (i.e that 
from Fig 12b), 25% of the original biological activity 
was recovered with 88^g of peptide. Since 2g of 
acetone-dried pituitaries (equivalent to about lOg 
of fresh pituitaries - see section 2.3) were used for 
this purification, this represents an overall increase 
in specific activity of about 2 8 000-fold relative 
to that in the fresh tissue, i.e. The purification 
factor was about 28 000.
Separation of MCH from MSH
Table 5 shows the degree of contamination of MCH with 
bioactive MSH throughout purification. Very small 
but significant amounts of MSH bioactivity persisted 
even in the most pure preparations of MCH obtained.
This residual contaminant is not a-MSH since calibrations
Fig. 9 Flow diagram for the purification of MCH from 
acetone-dried pituitaries
crude extract of 2g of acetone-dried , 
pituitaries prepared at room 
temperature in IM acetic acid














a variety of gradient profiles 
were tried on aliquots of the 
sample to try to resolve MCH 
from contaminating peptides
re-chromatography 
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Fig. 10
Gel-^filtration of MCH from ion-exchange of 2g of 
acetone-dried pituitaries (Fig. 8) on Sephadex G-25. 
The lyophilized sample was reconstituted in 3ml of 
1 M acetic-acid and applied to the 100 X 1.6cm column 
which was eluted with the same solvent at a flowrate 
of 7.7 ml h ^. Fraction volume was 2ml. The elution 
positions of the synthetic peptides desacetyl-a-MSH 
(i.e. I-I3NH2 ) and ACTH 1-24 were determined in a


























Fiq. 11 Semi-preparative scale HPLC (system 1) of 
MCH from 2g of acetone-dried pituitaries after ion- 
exchange and gel-filtration. Open histogram = bioactive 
MSH, stippled histogram = MCH. The sample from gel- 
filtration (in IM acetic acid) was applied directly to 
a 300 X 8mm column of Partisil-lO-ODS operated at a 
flowrate of 3ml min ^. The sample was followed by a 
simple linear gradient (broken line) from 0-80% methanol 
Peptides were detected by their absorbance at 280nm.
Fig. 12 HPLC (system 2) of MCH from 2g of acetone- 
dried pituitaries after purification by ion-exchange, 
gel-filtration and HPLC (system 1). Open histogram 
= bioactive MSH, stippled histogram = MCH. Aliquots of 
one tenth of the sample were applied to a 100 X 5mm 
column of Nucleosil-5-ODS operated at a flowrate of 
1.0 ml min  ^with sucessive modification of the gradient 
profile * a and b. Detection wavelength was 225nm,



























































Purification of MCH from 2g of acetone-dried pituitaries: 








crude extract 100 100 2 400
ion-exchange and 
gel-f iltration 60 0,33 8.0
HPLC (system 1) 35 0.40 9.5
HPLC (system 2) 
(gradient runs) 25 0.014 0.34
HPLC (system 2) 
(isocratic run) 9 0.0063 0.15
*= determined by comparison to the bioassay standard 
described in "methods' (section 2.5).
**= determined by comparison to a-MSH standard.
Recovery of MCH was estimated quantitatively after 
pooling fractions on the basis of qualitative MCH bio- 
assay. This was necessary to reduce the number of 
samples to be assayed to within the capacity of the
bioassay (see section 3.5a).
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of the HPLC system 2 with synthetic a-MSH had shown 
this to elute later than MCH and its contaminating 
MSH bioactivity.
b) Purification of MCH from lyophilised pituitaries
The procedure used for purification of MCH from the 
heated extract of lyophilised pituitaries was essentially 
the same as that for purification from the acetone 
powder. Since quantitative use of the MCH bioassay 
had shown that MCH could be recovered from all of 
the methods used, in this purification bioassays were 
used qualitatively - sufficient to locate peaks of MCH 
among the chromatographic fractions. In this purification 
mercaptoethanol was included at 0 .1% v/v for extraction 
and 0 .01% for chromatography to avoid methionine- 
sulphoxide formation (see section 3.6a).
Ion-exchange chromatography of the crude extract is 
described in section 3.3 Fig 8c. Two MCH peaks were 
found as before but they eluted earlier indicating 
that they were less basic than those from the unheated 
extract of acetone-powder. The first of these was 
taken for further purification since it was essentially 
free of MSH.
Gel-filtration of this sample on Sephadex G-25 gave 
a single peak of bioactivity which eluted in the same
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position as that purified from the acetone powder (see 
previous section). Thus, although this MCH appeared 
less basic than that purified from the acetone powder, 
it had the same apparent molecular weight. As before, 
the MCH bioactivity did not correspond to an absorbance 
peak.
When the MCH-containing fractions from, gel-f iltration 
were applied, without lyophilisation direct to HPLC 
system 2 (Fig 13) the sample gave a complex absorbance 
profile. Since the initial extraction had been 
performed at 100°C, it is unlikely that the complexity 
of this mixture was due to _in vitro proteolysis, 
a contingency which could not be excluded before. 
However, when these HPLC fractions were bioassayed 
for MCH, no activity was detected. The reason for 
this loss of bioactivity is unknown. Experiments 
on the stability of MCH in crude extracts (section 3.1) 
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Fig . 13 When MCH from 4g of lyophilized pituitaries was 
run on HPLC (system 2) as in Fig. 12 , peptides eluted 
earlier than expected resulting in poor resolution. The 
peptide-containing fractions were therefore diluted with 
an equal volume of water and re-run as shown with a 
modified gradient. No MCH was detected in fractions from 
this run or in the side-fractions from the initial run.
In each case the gradient was to 60% acetonitrile 
although only the region where peptides were detected 
i s shown.
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3.5 The measurement of melanophore-concentrating 
activity
a) The MCH bioassay
The MCH bioassay has proved difficult to use 
quantitatively because of unreliability in the quality 
of scales, specifically;
1) The melanophores of trout-scales in vitro, 
though dispersed initially, undergo slow spontaneous 
concentration to a variable extent in the absence of 
any applied stimulus.
2) There is great variation between scales
of the same fish in the response of their melanophores 
to a given concentration of MCH.
The spontaneous concentration which occurrs iu vitro 
was minimised by the routine inclusion of lO^'Sl 
Rogitine (an a-adrenergic antagonist) in the bioassay 
medium - which suggests it was caused by endogenous 
catecholamines. Spontaneous concentration does not 
occurr uniformly to all melanophores but appears to 
affect particular scales at random. Thus, to be 
sure that an observed response is due to an applied 
stimulus (e.g. added MCH) several scales have to be 
tested. This is so even for a qualitative determination 
i.e. to decide whether or not MCH is present. The 
bioassay used quantitatively consists of qualitative 
determinations at a variety of dilutions to establish 
the "threshold dilution" (section2.5); as this
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condition is approached, more scales are required for 
each successive test. In my experience this limits 
quantitative use of the bioassay to a few samples 
(up to six).
Since MCH-activity is measured in trout-units and 
since this measurement is derived from a dilution 
factor (section 2.5) it is a discrete or quantized 
variable; this precludes the use of standard-error 
estimates (i.e. mean ± SEM) in describing the precision 
of the data, since this is only valid for continuous 
variables.
Inter-assay variation
A study of inter-assay variation using the standard 
preparation described, in section 2.5 showed that 
in nine separate assays the apparent MCH-content 
of Img of acetone-dried pituitary powder ranged from 
20 - 300 trout-units with a mean of 93 trout-units.
i.e. On average, a solution of Img of the pituitary 
powder in about 9.3ml was just detectable.
b) The measurement of melanophore responses by 
microdensitometry
Two major disadvantages of the MCH bioassay are; the 
quantized nature of the measurement obtained, and the 
inacurracy of the subjective assessment off melanophore
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responses. Microdensitometry was used in an effort 
to improve these aspects of the bioassay by generating 
continuous data and by measuring melanophore responses 
accurately and objectively. In the ensuing experiments, 
for convenience, noradrenaline has been used to induce
melanophore-concentration.
Fig 14 shows the precision with which area-measurements 
can be made on a single living melanophore using the 
microdensitometer, and also demonstrates that the 
response is not the "all or none" type since a 
stable state of intermediate concentration was attained. 
Unfortunately, the recovery-time of trout-scale 
melanophores in vitro (>30 min) is too long to allow 
replicate observations to be made on the same 
melanophore. Therefore, to investigate the dose- 
response relationship to noradrenaline, the same 
approach was used as for the MCH bioassay; scales 
bearing dispersed melanophores were incubated in 
test-solutions, and after a prescribed time (in this 
case Ih) the area of the melanophores was measured.
A dose-response curve was constructed by plotting 
change in melanophore area { %  response ) as a function 
of noradrenaline concentration (Fig 15). Extensive 
spontaneous melanophore-concentration occurred in 
the absence of Rogitine which obscured the effect 
of added noradrenaline. However, in this case, the 
presence of 10 ^M Rogitine prevented spontaneous
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concentration. Under these conditions, added 
noradrenaline caused melanophore-concentration in 
a dose-dependant manner and at 10 - completely
overcame the effect of 10”^  Rogitine. The observation 
that noradrenaline was able to overcome the blocking 
effect of Rogitine indicates that Rogitine acts as 
a competetive antagonist of noradrenaline as it does 
on the tailfin melanophores of Pterophyllum eimekei 
(Finnin et al 1979).
The apparent log-linear nature of the lower part of 
the dose-response curve indicates that the area 
measurement might be a good basis for a quantitative 
bioassay. However, there was great variation between 
trout-scale melanophores in their response to a given 
concentration of noradrenaline and large numbers of 















Fig. 14 The response of a single trout-scale melanophore 
to 10 noradrenaline measured with the flying-spot 
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log concentration of Noradrenaline
Fig. 15 The effect of noradrenaline on trout-scale 
melanophores in the presence (O) and absence (•) of 
10""^ Rogitine. Five melanophores selected at random 
from each of five scales were measured for each data- 
point; values are means ± SEM, n=25. MI=melanophore- 
index.
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3 .6 Purification of MSH 
Introduction
Since both MCH and MSH are implicated in the control 
of teleost melanophores, it is important to our 
understanding of how their actions are co-ordinated 
to have some idea of the amounts of each which exist 
in the pituitary in terms of both mass and biological- 
activity.
The availability of a radioimmunoassay for a-MSH has 
enabled measurement of the mass of "immunorea ctive 
a-MSH" in crude pituitary extracts (section 3.11). 
However, when the identity of an immunoreactive 
substance is uncertain and therefore its degree of 
cross reactivity is unknown, large errors can result 
in its estimation by radioimmunoassay, and ultimately 
its precise identity can be established only by isolation 
and chemical analysis.
From the results of section 3.2 on the chromatographic 
behaviour of MCH and MSH, it was evident that MCH 
was a peptide with physicochemical properties similar 
to those of the MSH*s. It was considered therefore 
that purification of the MSH's of trout pituitary in 
parallel with MCH would provide a useful comparison 
since susceptibility to loss or damage during : 
purification should be similar.
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Thus, to enable comparison to MCH in terms of mass per 
pituitary and to establish the identity of the immuno- 
reactive MSH's - one of these was purified. The 
second immunoreactive-a-MSH from ion-exchange (Fig 8 ) 
was taken because at this stage it was purer than 
the first as judged by the absorbance trace (not 
shown).
a) Purification of desacetylTa-MSH like peptides from 
acetone-dried pitùitaries
The purification of these peptides is summarised 
in the flow diagram (Fig 16).
The second immunoreactive a-MSH peak from ion- 
exchange chromatography (Fig 8a) was further purified 
by gel-filtration on Sephadex G-25 (Fig 17). MSH 
bioactivity was confined to the main absorbance peak 
of the chromatogram. The specific-actiVity of this 
peptide preparation (i.e. bioactivity per unit mass) 
was 10% that of synthetic a-MSH measured in the same 
bioassay, i.e. the same as that of desacetyl-a-MSH 
(see section 3.3). However, its elution position 
suggested it was somewhat smaller than desacetyl- 
a-MSH.
N-terminal determination by the dansyl method showed 
this peptide to be heterogeneous, so an aliquot (1/ 1 0 ) 
was subjected to further purification on HPLC system 2 
(Fig 18). The absorbance trace showed only two major
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peptide components - A and B . No bioassay was performed 
since it was evident from Fig 17 that the biologically 
active peptides had been major components of the 
applied mixture.
Structural analysis
The results of amino-acid analyses, N-terminal 
determinations and a-MSH radioimmunoassay of peaks 
A and B are given in Table 6 . Their strong immuno- 
reactivity with the C-terminally directed a-MSH 
antiserum suggested similarity of their C-termini 
with a-MSi / desacetyl-a-MSH i.e. -Lys-Pro-Val-C0NH2 •
The amino-acid compositions of peptides A and B were 
similar to that which would be expected for a-MSH 
or desacetyl^a-MSH. Indeed, that of B was essentially 
identical.
Since B had a free N-terminal serine residue, this 
would suggest it was desacetyl-a-MSH since the acetyl 
group at the N-terminal of a-MSH renders it unremotive to 
dansyl chloride. However, desacetyl-a-MSH is a 
C-terminal amide and with the data considered so far, 
peptide B could be either a C-terminal acid or a 
C-terminal amide (since the acid hydrolysis of peptides 
converts amides to acids).
From their amino-acid compositions (Table 6 ) peptide 
preparation A would appear to be a mixture of N-
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Evidence from mass-spectrometry (see section 3.7a) 
suggested that peptide A(i) was a C-terminal amide.
Since peptides A(i),(ii) and B co-eluted during 
purification on ion-exchange chromatography (Fig 8a) 
it is likely that they all were C-terminal amides.
The N-terminal Met residue of A(i) appeared from 
mass-spectrometry to be Met sulphoxide. Oxidation 
to the sulphoxide could easily have occurred during 
purification and / or storage. The sulphoxide was not 
detected by amino-acid analysis because of the presence 
of mercaptoethanol in the hydrolysing acid (6M HCl) 
which reduces this back to methionine.
To avoid oxidation of methionine in later purifications, 
mercaptoethanol was included at 0 .1% v/v for extraction 
and 0.01% v/v for chromatography. To detect Met 
sulphoxide should it occurr, hydrolysis of peptides
Fig. 16. Flow diagram for the purification of g-MSH- 
like peptides from acetohe-dried pituitaries
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crude extract of 2g of acetone-dried 
pituitaries prepared at room 
temperature in IM acetic acid


















on Sephadex G-25 
(Fig. 17a)






Sephadex G-25 gel-filtration of immunoreactive -a-MSHVs 
from ion-exchange of 2g of acetone-dried pituitaries 
(Fig 8a). The lyophilised samples were reconstituted in 
3ml of IM acetic acid and applied to the 100 X 1.6cm 
column which was eluted with the same solvent at a 
flowrate of 7.2ml h ^. 2ml fractions were collected and
assayed for MSH using the Anolis bioassay. In the 
desacetyl-a-MSH-like peptide from ion-exchange appeared 
smaller (i.e. eluted later) than did synthetic desacetyl- 
a-MSH run on the same column. Therefore, since its 
identity was still uncertain, it was committed to further 
purification on HPLC (Fig 18). In b the a-MSH-like 
peptide was similar in size to synthetic desacetyl-a-MSH 
(and therefore similar in size to a-MSH). The absorbance 
trace suggested that this peptide was still impure, 
nevertheless it was more biologically potent than the 
desacetyl-a-MSH-like peptide. These observations 
further support its putative identity as a-MSH.



















































































0  20 
elution volume (ml)
Fig. 18 HPLC (system 2) of desacetyl-a-MSH-like peptide 
obtained from ion-exchange and gel-filtration of an 
unheated extract of 2g of acetone-dried pituitaries.
One tenth of the sample from gel-filtration (in IM 
acetic acid) was applied directly to a 100 X 5mm column 
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for amino-acid analysis was hereafter performed in 
6M HCl without mercaptoethanol.
Overall purification and yield
Treating these desacetyl-a-MSH-like peptides collectively 
as desacetyl-a-MSH, yield was 89% and the purification 
factor was about 14 000. (Yield was estimated by 
radioimmunoassay see section 3.11a). Thus desacetyl- 
a-MSH could be isolated in pure form with considerably 
less purification than MCH which was still impure 
after a 28 000 fold purification.
b) Purification of desacetyl-a-MSH-like peptides 
from lyophilised pituitaries
The purification of these peptides is summarised in 
the flow diagram (Fig .19).
The second peak of immunoreactive-a-MSH obtained from 
ion-exchange of a heated extract of the lyophilised 
pituitaries (Fig 8 c) unlike that from the acetone- 
powder (Fig 8 a) did not correspond to a peak of bio­
activity. The fractions comprising this immunoreactive 
peak were pooled serarately from those of the following 
bioactive peak and each of these in turn was applied 
to Sephadex G-25; the resulting chromatograms were 
very similar (Fig 20).
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Fig. 19. Flow diagram for the purification of des- 
acetyl-g-MSH-like peptides from lyophilised pituitaries
N.B. mercaptoethanol was included during this purification 
at 0 .1% v/v for extraction and 0 .01% v/v for chroma­
tography. The initial extract was prepared at 100°C.
crude extract of 4g of lyophilised pituitaries 
prepared in IM acetic acid
ion-exchange on SP-Sephadex (Fig. 8c)
peak 1 peak 2 ^eak 3








Gel-filtration of desacetyl-a-MSH-like peptides 
from ion-exchange of 4g of lyophilised pituitaries 
(Fig 8c) on Sephadex G-25. The second immunoreactive 
a-MSH peak (a) and the neighbouring bioactive MSH 
peak (b) from ion-exchange were lyophilised, re­
constituted in 1.0ml of IM acetic acid (including 
mercaptoethanol) and applied to a 77.5 X 1.1cm 
column of Sephadex G-25 eluted with the same solvent 
at 3.8ml h ^ . Fractions were pooled as indicated on 
the basis of the absorbance trace.
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Structural analysis
The peptide-peaks taken from Fig 20 were subjected 
to amino-acid analysis (Table? ). Essentially integral 
ratios of residues were found indicating that these 
peptides were pure so they were not subjected to 
further purification by HPLC.
Hydrolysis in 6M HCl without mercaptoethanol showed 
no trace of methionine sulphoxide in any of these 
peptides suggesting that the presence of mercapto­
ethanol during purification had either prevented or 
reve rsed mèthionine-oxidation»
The desacetyl-a-MSH like peptide common to both 
chromatograms of Fig 20 was desacetyl-a-MSH as shown 
by mass-spectrometry (see the next section).
No N-terminally shortened dervatives of desacetyl- 
a-MSH were found in this purification; since heat was 
used during the initial extraction, this supports the 
notion that those purified from the unheated extract 
of 2g of acetone-dried pituitaries are artifacts of 
proteolysis.
In addition to desacetyl-a-MSH, a higher molecular- 
weight (i.e. earlier eluting) peak was observed on 
gel-filtration (Fig 20b). This was not evident in the 
corresponding chromatogram from the acetone-powder
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(Fig 17). Its amino-acid composition (Table 7) 
suggested that it was similar to a-MSH II - a penta- 
decapeptide purified from salmon pituitaries by 




however, a-MSH II has only 2 His residues whereas 
this peptide has 3 (Table 7). Amino-acid analysis 
of solvent blanks showed traces of Gly, His, Lys 
and NHg where MESNA was used but only NH^ where HCl 
was used. These contaminants were insufficient to 
account for the high His value which was determined 
in hydrolysates of both acids and it would appear 
that the a-MSH-Il-like peptide does indeed have 
three His residues.
Overall purification and yield
From a heated extract of 4g of lyophilised pituitaries 
2.48mg of pure undamaged desacetyl a-MBH was obtained 
which represents a yield of 103% and a purification 
factor of about 8 000. Thus purification of desacetyl 
af^MSH was easier from the lyophilised pituitaries 
than from the acetone powder (pf. 14 000) because of the 
preponderance of the desacetyl form of a-MSH and since 
heat precluded damage by proteolysis obviating the need
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for further purification by HPLC.
Estimation of % yield or purification factor is not 
possible for the a-MSH-II-1ike peptide since there was 
no way of estimating it in the crude extract. (Desacetyl- 
a-MSH was estimated by radioimmunoassay after separation 
by ion-exchange, see section 3.11a). Similarly 
Kawauchi et al (1981) were unable to express their 
results in this fashion when they purified MSH's 
from salmon pituitaries. Therefore the results of 
this purification are compared to those of Kawauchi 
et al (1981) in Table 8 in terms of mg of peptide 
obtained per lOOg wet weight of pituitaries;
Table 8
Yields of a-MSH*s after purification from 4g of 
lyophilised pituitaries compared to those of Kawauchi 
et al (1981)
peptide yield in mg/lOOg wet weight




a-MSH-II-like peptide 4 -
a-MSH (3)* 4
* calculated value assuming that the first immuno­
reactive -a-MSH to elute from ion-exchange (Fig 8a) was 
a-MSH (see Fig 17b).
Thus the results of this purification were remarkably 
similar to those of Kawauchi et al (1981) though 
whether of not these are typical is uncertain since 
in the corresponding purification from 2g of acetone 
powder no a-MSH^II-like peptide was found and the 
acétylation status of a-MSH differed.
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3.7 Fast-atom bombardment mass-spectrometry of des­
acetyl-a-MSH like peptides purified from salmon 
pituitaries
Introduction
The new technique of fast-atom bombardment (FAB) 
mass-spectrometry (Barber et al, 1981; Williams et 
al, 1981a,b) enables molecular-weight and sequence 
information to be obtained on nmol quantities of 
underivatised peptides. This method c^n determine 
directly the presence of labile substituent groups 
which might otherwise be changed or lost by conventional 
hydrolytic procedures or by the permethylation 
procedure used in electron-impact mass-spectrometry.
In FAB-spectra of peptides, the most abundant peak 
(excluding low-mass background) is usually that of 
the molecular ion. This enables accurate determination 
of molecular weights up to about 2 000 daltons. Of 
the types of fragmentation which occurr in FAB mass- 
spectrometry of peptides, the two most common and 
most useful have been identified (Williams et al,
1981b)*
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Whether the resulting sequence . ions carry a net- 
negative or a net-positive charge is in part determined 
by the acid / base characteristics of the residues 
which they contain (Ions with net charges greater 
than unity are not seen in FAB spectra). Thus peptides 
containing a preponderance of basic residues (Arg,
Lys and to a lesser extent His) generally give good 
positive ion spectra, conversely acidic residues 
favour negative ion spectra.
Whether N-terminal sequence-ions or C-terminal 
sequence-ions predominate depends on the distribution 
of charged sites in the peptide. In some cases the 
occurrence of both enables complete sequence 
determination.
a) Mass-spectrometry of peptides purified from 
lyophilised pituitaries
The FAB positive-ion mass-spectrum of the desacetyl- 
a-MSH like peptide from Fig 20a is shown (Fig 21).
In this peptide, where basic residues predominate 
toward the C-terminal, only positively-charged C- 
terminal fragments (+ CA and + C Aik) are seen. The 
identification of such fragments is facilitated by 
their characteristic separation by 15 mass-units.
The molecular ion MH^ at 1622 daltons is one mass-unit 
less than that predicted from the amino-acid composition
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(Table 7). This mass-difference of 1 is perpetuated 
throughout the spectrum. It strongly indicates the 
existence of an amide group in the cryptic C-terminal 
portion of the peptide (i.e. the C-terminal 7 residues). 
From thé amino-acid composition the Glx residue side- 
chain is the only site other than the C-terminal 
which could have borne an amide group; since this is 
defined by the mass-spectrum as Glu and not Gin - this 
peptide must be a C-terminal amide.
Since the molecular weight of this peptide differs 
by only one mass unit from that predicted by its 
amino-acid composition, we know that it does not 
contain an acetyl group at any site. e.g. &-MSH 
gives a molecular ion of 1664 daltons rather than 
1622 daltons due to the presence of the acetyl group at 
the N-terminal.
The desacetyl-a-MSH like peptide from Fig 20b gave 
an identical spectrum to that shown in Fig 21.for the 
corresponding peptide of Fig 20a and since their 
amino-acid compositions were also identical it is con­
cluded that they are the same . From the foregoing, 
the structure of this peptide has been determined as:
NHg-Ser-Tyr-Ser-Met-Glu-His-
(Phe Arg Trp Gly Lys Pro Val )C0NH2
Brackets denote unspecified order.
Fig 21
Fast-atom bombardment positive-ion mass-spectrum of the 
desacetyl-a-MSH-like peptide from Fig 20a. This spectrum 
was obtained with a sample of about lOnmol. The major 
peak at ig/z 1622 represents the intact peptide molecule 
carrying a single net positive charge, i.e. the mol­
ecular ion: MH^. The characterisitic separation of 
sequence-ion peaks by 15 mass-units indicates that the 
main type of fragmentation occurring in this spectrum 
is of the second type described in the text, where 
charge is retained by the C-terminal fragment. These 
peaks therefore represent fragments of the molecular- 
ion which have lost various numbers of residues (0-6 ) 
from the N-terminal. The identity of these residues 
is deduced from the table below.
Table 9 Integral masses of amino-acid residues
Gly 57 Leu 113 Met 131
Ala 71 lie 113 His 137
Ser 87 Asn 114 Phe 147
Pro 97 Asp 115 Met(O) 147
Val 99 Lys 128 Arg 156
Thr 101 Gin 128 Tyr 163
Cys 103 Glu 129 ' Trp 186

















The a-MSH II like peptide from Fig 20b was similarly 
subjected to FAB mass-spectrometry, but no peptide 
attributable peaks were detected. According to its 
amino-acid composition the molecular weight of this 
peptide is 1881 daltons, not^accounting for the 
possible presence of an acetyl group at the N-terminal 
which would increase this by 42 daltons. This is 
close to the present upper mass-limit of about 2 000 
daltons beyond which ions are undetectable and this 
may explain failure to detect peptide-peaks in the 
mass-sp ectrum.
b ) Mass-spectrometry of peptides purified from acetone- 
dried pituitaries
Positive-ion FAB mass-spectrometry of a 5nmol sample 
of peptide preparation A (see section 3.6a) gave a 
molecular ion (MH^) of 1301 daltons and two sequence ions: 
+ CA at 1154, and Aik at 1139 daltons due to the 
loss of a single residue from the N-terminal by type 
II fragmentation. The m^ss of the molecular ion 
was such that it could only have been caused by the 
major component of this peptide mixture, i.e. A  (i), 
since the calculated mass of the other component
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A(ii) was greater than 1301 daltons. However, the 
mass of the molecular ion was 15 daltons greater 
than that calculated for A(i) assuming it to be a 
C-terminal acid, or, 16 daltons greater assuming it 
to be a C-terminal amide (because COOH is 1 dalton 
greater than CONH2 )• We know from the mass-difference 
between the molecular ion and the sequence ions 
that the mass of the N-terminal residue is 147 daltons. 
This, similarly, is 16 greater than that expected 
for an N-terminal methionine residue, and as such, 
could be due to either Phe or Met sulphoxide (see 
Table 9). It would appear therefore that the N-terminal 
residue was Met sulphoxide and since this accounts 
for a mass-difference of 16 and not 15, this indicates 
the presence of an amide rather than an acid group 
at the C-terminal.
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3 .8 A comparison of hypothalamic and pituitary forms 
of MCH and MSH
Ranee and Baker (1979) have shown that MCH is present 
in the hypothalamus of Salmo qairdneri in equal 
or greater amounts than in the pituitary; the only 
indication that the two "pools'* are connected in 
any way is their finding that the relative amounts 
vary according to background. Are hypothalamic and 
pituitary forms the same? - this could have important 
implications for the biological function of MCH 
(see discussion). Ranee and Baker (personal 
communication) have already shown that both forms have 
the same mobility on polyacrylamide gel electrophoresis 
at acid pH. To study this further, hypothalamic 
and pituitary MCH's have been compared by gel-filtration 
and in each case the relationship to MSH*s (bioactive 
and immunoreactive) has also been compared (Fig 22). 
Fresh tissue from trout (Salmo qairdneri) was used for 
these experiments because salmon hypothalami were 
not available.
Fig 22 shows that MCH from each source has the same 
apparent molecular weight, and that more was obtained 
from the hypothalamus. This is consistent with the 
hypothesis that the two pools are linked by axonal 
transport, but the relative abundance (more in the 
hypothalamus) is the converse of that expected 
for a neurohypophysial hormone (see section 1.5).
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In the cases of both pituitary and hypothalmic 
extracts MCH co-elutes with the immunoreactive a- 
MSH peak - indicating that they are of similar 
molecular weight (non-identity has already been 
demonstrated by purification).
In the case of the pituitary extract, the a-MSH 
immunoreactivity eluted a little later than the 
peak of MSH bioactivity. This is probably because 
the bioactive peak is composed of a mixture of a- 
and p- MSH's, whereas the immunoreactive peak rep­
resents only the a-type MSH*s (see section 3.3).
The hypothalamic immunoreactive a-MSH elutes in about 
the same position as desacetyl a-MSH , suggesting 
that some of the MSH bioactivity of the hypothalamus 
is attributable to a-MSH in its acetyl and / or 
desacetyl forms(Fig 22b).
The anatomical proximity of the hypothalamus and the 
pituitary and the very low amounts of MSH present 
in the hypothalamus relative to the pituitary make 
it eminently possible that hypothalamic "MSH" is in 
fact a contaminant from the pituitary. Although 
every precaution was taken to avoid this during 
their dissection and homogenisation - the possibility 
is still admissible. However, an observation which 
could not be explained by the occurrence of such 
contamination is the profound difference in molecular
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weight distribution of bioactive MSH from the two 
sources. Although it could be argued that the hypo­
thalamic immunoreactive a-MSH was due to contamination, 
this would not explain the higher molecular weight 
forms of bioactive MSH which occurr in the hypo- 
thalamus.
Fig 22
Comparison of pituitary (a) and hypothalamic (b) 
forms of MCH and MSH by gel-filtration on Sephadex 
G-25. Open histogram = MSH bioactivity; stippled 
histogram = MCH bioactivity; a-MSH immunoreactivity 
= •— • . The pituitaries and hypothalami of 35 rainbow 
trout were homogenised in boiling IM acetic acid 
(10ml in each case). The pituitary extract was 
lyophilised, reconstituted in 1.0ml of IM acetic acid 
and applied to the column (75 X 1.1cm) which was eluted 
at 4ml h  ^ in the same solvent. Fraction volume was 1ml. 
The hypothalamic extract was treated identically except 
that, before lyophilisation, the homogenate was de­
fatted with chloroform / methanol. The fish used in 
this experiment were 1-2 years old and were killed 
immediately after arrival at the laboratory. Mercapto- 
ethanol was present at 0 .1% v/v for extraction and 



































































3.9 A hypothalamic inhibitor of MCH
Recovery of MCH from gel-filtration of the pituitary 
extract described in Fig 22a was about 80%. However, 
in an attempt to measure the recovery of MCH from 
the defatted hypothalamic extract of Fig 22b, no 
activity could be detected in a retained sample of 
the extract. This meant that the whole of the 
applied sample contained less than 7% of the activity 
recovered from gel^-filtration. Occasional failure 
to detect MCH activity in crude hypothalamic extracts 
had previously been attributed; simply to over-dilution 
of the extract, but it now appears that the activity 
may have been suppressed by an inhibitory factor.
To try to localise the "inhibitor” among the chrom­
atographic fractions, four pools were made (Fig 22b): 
the exclusion peak; the MCH peak; and the fractions 
which eluted before and after MCH -”pre" and 
"post-MCH". Samples of 1/10 of the MCH peak were 
mixed with 1/10 of each pool. Another sample "complete 
re-mixture" was comprised of 1/10 of every pool.
As control, 1/10 of the MCH pool was taken. Each 
of these samples was lyophilised (to remove acetic- 
acid and mercaptoethanol) and reconstituted in 50^1 
of MCH bioassay medium. The results of MCH bioassay 
of these samples are shown in Table!10.
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Table 10












1 + + + - -
Vs + + + - -
Vl6 +/- +/- + - -
V s  2 - - - - -
+ = strong response 
+/- = threshold response 
- = no response
Three scales were 
used for each 
determination
From Table 10 the inhibitor is clearly localised to 
to the post-MCH pool indicating it is of smaller 
molecular weight than MCH. The inhibitor was capable 
of reducing MCH activity by at least 16-fold. When 
all of the fractions were remixed, MCH activity was 
similarly abolished - confirming the original 
observation that activity in the crude extract was 
suppressed. Although the inhibitor can oppose the 
action of MCH on trout melanophores, whether it has 
intrinsic melanophore-dispersing activity was not 
determined. However, the inhibitor fraction was 
essentially free of Anolis melanophore-dispersing
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activity (i.e. "MSH bioactivity"), suggesting that 
the inhibitor was not a type of MSH. The activity 
of MCH is not suppressed in crude pituitary extracts 
where a-> and g-MSH * s are present in great excess of 
MCH; this also suggests that the inhibitor is not 
a type of MSH.
Having previously calibrated the gel-filtration 
column with adrenaline, we know that the inhibitor 
fraction would incorporate the catecholamine 
fraction of the hypothalamic extract. Although the 
usual response of teleost melanophores to catecholamines 
is one of melanin aggregation, Miyashita and Fujii 
(1975) have shown that very low concentrations of 
catecholamines can cause dispersion (see section 
1.2a). Thus, the inhibitor could be a catecholamine(s) 
acting on ^-adrenoceptors (since a-receptors were 
blocked by the presence of Rogitine in the bioassay 
medium). Time did not permit an investigation of 
the nature of the inhibitor, but this could be studied 
by testing its stability to proteases to see if it 
is a catecholamine or a peptide.
Although the physiological significance of this 
inhibitor is uncertain, it is important practically 
as it may explain why Kent (1959) was unable to 
detect MCH activity in the hypothalamus of Phoxinus
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The realization of the existence of an inhibitor 
urges caution in deciding whether a tissue lacks MCH. 
Indeed a re-investigation of its phylogenetic occurrence 
may be warranted (e.g. can MCH be detected in mammalian 
hypothalamus after gel-filtration?).
More MCH can be detected in slices of hypothalamus 
(see Fig 1 in methods) than when fragments of hypo­
thalamus - such as those used in this study are 
taken (Dr. B. Baker, personal communication). This 
might reflect an anatomical separation of nuclei 
containing MCH and the inhibitor.
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3.10 Estimation of the molecular-weight of MCH
In section 3.8 crude extracts of trout pituitaries 
and hypothalami were chromatographed on Sephadex G-25 - 
a gel-filtration medium. How well a molecule penetrates 
into the gel beads is determined by its molecular size 
which for peptides (which do not have a stable three- 
dimensional conformation) is closely correlated with 
molecular weight. The degree of penetration is measured 
by determining the elution position of a peptide 
relative to that of a molecule which is totally 
excluded from the gel beads ( in this case BSA).
The resulting Ve/Vo values are inversely proportional 
to log molecular weight. This is how Fig 23 was 
constructed.
The data of Fig 22 were used to determine the elution 
position of MCH because conditions were optimal for 
the preservation of MCH - i.e. fresh material was used 
and extraction was performed in boiling acetic-acid.
The column was operated with a peristaltic pump and 
elution positions were determined on the basis of 
time since this was found to be more reproducible 
th&n drop-count. The resulting molecular-weight 
estimate (1 700 daltons) is approximate only because 












Estimation of the molecular weight of MCH. The elution 
position of MCH on sephadex G-25 as determined in Fig.
22 was compared to that of various standard peptides 
of known molecular weight determined in separate runs 
on the same column. Ve, elution volume; Vo, void volume.
A, desacetyl-a-MSH; B, a-MSH; C, a-MSH-II-like peptide;
D, ACTH 1-16.
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3.11 The use of radioimmunoassays for g-MSH and ACTH 
Introduction
The pituitary content of any given hormone may be 
subject to large variation depending on the phsiological 
demand for it since it is a net function of rates of 
biosynthesis and secretion. It was deemed desirable 
therefore to compare the pituitary content of MCH to 
that of a variety of other peptide hormones. To this 
end, radioimmunoassays for a-MSH and ACTH were 
evaluated for use in measurement of the pituitary 
content of these peptides.
a) Immunoreactive a-MSH content of salmon pituitaries
Heated extracts of the commercial acetone-dried 
and lyophilised pituitary preperations ( those described 
for Fig 7 b and c) were compared by radioimmunoassay 
for a-MSH. (Fig 24). Both extracts gave parallel 
competition curves suggesting similarity of the 
immunoreactive components of the extracts with the 
C-terminal end of a-MSH since the a-MSH antiserum is 
C terminally specific. Although this parallelism 
validates the quantitative use of the assay, this is so 
only in a relative sen&e, since 100% cross-reactivity 
is not a prerequisite of parallelism (see section 2.8 
Table 1). In other words: although two values 
determined by radioimmunoassay may be compared to 
one another, in absolute terms (i.e. in ^ q )  they
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are liable to be underestimates.
Validation of the use of this assay in absolute terms 
comes from the realization that the major immunoreactive 
component of the extracts is desacetyl-a-MSH (see 
section 3.6) which has high (70%) crossreactivity 
with the antiserum. The other component is probably 
a-MSH (see section 3.6a)
Therefore in crude extracts .this radioimmunoassay measures 
a-MSH and desacetyl-a-MSH together, and depending on 
their relative amounts, values are liable to be 
underestimated by up to 30% (because crossreactivity 
with desacetyl-a-MSH is 70%).
Estimates of the a-MSH content of the pituitary 
powders determined by assaying the extracts described 
for 7b and 7c and subject to the vagaries of the 
preceeding paragraph are given in Table 10 as "apparent 
a-MSH content". However, having separated a-MSH and 
desacetyl-a-MSH by ion-exchange (Fig 8 ) and knowing 
their crossreactivities (Table 2 : 100% and 70% 
respectively) it is possible to jnake a more accurate 
estimate of the amounts of each which exist in 
absolute terms (Table 11)
Fig. 24 Immufnoreactive a-MSH of salmon pituitaries.
Extracts of the commercial pituitary powders prepared in
boiling acetic acid (i.e. those described for Fig. 7 b and
c) were compared to synthetic a-MSH by radioimmunoassay.
In each case, a 2-fold serial dilution of the extract (o)
is compared to a similar series of a-MSH standards (•).
Values are means of duplicate estimations. The zero-level
125on the y-axis denotes % I-a-MSH bound in the absence
of a-MSH. The extracts caused complete displacement of
125specifically-bound I-a-MSH, and the slopes of the




























Immunoreactive-g-MSH content of the commercial 
pituitary powders estimated by radioimmunoassay 
of heated extracts.
peptide content pg g ^
apparent-a-MSH* a-MSH desacetyl-a-MSH
acetone-dried
pituitaries 448±32.6 197 358
lyophilised
pituitaries 525±19.8 105 600
* Values are mean ± SEM, n=4 estimation on a single 
extract. Ig of pituitary powder = about 192 pituitaries 
= about 5g wet wëight.
b) Immunoreactive ACTH content of salmon pituitaries
The unheated extract of acetone-dried piuitary powder
described for Fig 8a was analysed for its content of
immunoreactive ACTH using a commercial hACTH antiserum
(Fig 25). The cross-reactivity of this antiserum
with synthetic a-MSH at 50% displacement was found
to be 6 .5% in molar terms, and was probably due to the
sequence-identity of a-MSH (except for its acetylated
N-terminal) with the first 13 residues of hACTH. The
125specific binding of I-pACTH to the antiserum could 
be completely prevented by a-MSH indicating that 
the antiserum was directed toward the N-terminal
122
region of hACTH.
Both a-MSH and the pituitary extract gave competition 
curves which differed in slope from the hACTH standard 
precluding measurement of the ACTH-content of the 
extract (Fig25). The slope of the piuitary-extract 
curve was closer to that of a-MSH than to that of 
the hACTH standard suggesting that the predominant 
immunoreactive component(s) of the extract were more 
akin to a-MSH than to hACTH. These results suggest that 
the ACTH-content of salmon pituitaries is low relative 
to that of a— MSH-like peptides, i.e. the ACTH immuno­
reactivity detected here can be mostly accounted 
for by a-MSH and desacetyl-a-MSH.
These findings are in accord with those of Kawauchi 
et al (see 1982) who were unable to detect ACTH in 
salmon pituitary extracts (chemically rather than 
immunologically) despite having isolated two classes 
each of a-MSH and CLIP.
However, Scott and Baker (1975) using ACTH antisera 
which did not cross-react with a-MSH found comparable 
levels of a-MSH and ACTH in the pituitary of Salmo 
qairdneri by radioimmunoassay, and there is no doubt 
that teleost pituitaries contain ACTH.
Such differences could easily be explained by differences
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in the physiological state of the animals when killed, 
e.g. factors such as stress and state of background 
adaptation might profoundly affect the relative 
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Immunoreactive "ACTH" of salmon pituitaries. An extract 
of the acetone-dried pituitary powder (i.e. that 
described for Fig 8a) was compared to hACTH and to 
Ct-MSH using the ACTH radioimmunoassay. A 2-fold 
serial dilution of the extract (■) is compared to 





4.1 The Chemical nature of MCH
Since MCH was never isolated in pure form, direct 
knowledge of its chemical structure is not available. 
Nevertheless, certain deductions can be made about 
aspects of its chemical structure.
The concentrating activity of MCH on teleost melano­
phores, unlike that of catecholamines, appears to be 
insensitive to a-adrenergic blockade (section 3.5a).
The activity of MCH is not decreased by oxidation 
with hydrogen peroxide (section 3 .Id) - an observation 
which further contrasts it to the catecholamines 
which are readily inactivated by oxidation. Similarly, 
the inactivation of MCH by trypsin (section 3.1a) 
suggest it is a peptide and not a catechoalmine. This 
is also true of its apparent molecular-weight from 
gel-filtration (section 3.10) and its retention by 
hydrophobic HPLC media (e.g. section 3.2b). Thus the 
melanophore-concentrating activity of teleost pituitary 
extracts appears to be due to a peptide and not 
catecholamines.
Because the mobility of MCH in thin-layer electrophoresis 
is very similar to that of a-MSH (section 3.2d) and in 
view of the similarity in their molecular weights, 
it would appear that their net charges (at pH 4.4)
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are similar. This would imply the existence of two or 
more of the basic residues (Arg, Lys or His) in the MCH 
molecule. This is consistent with the cationic behaviour 
of MCH during ion-exchange chromatography (section 3.3) 
and with its sensitivity to trypsin which suggests the 
presence of Arg and / or Lys (section 3.1a).
The gross physicochemical properties of MCH from cod 
pituitaries have recently been investigated by Bird- 
Westerfield et al (1980) using a qualitative _in vivo 
bioassay based on the subjective assessment of pallor 
in the excised tails of Fundulus after intraperitoneal 
injection of pituitary extracts. They found MCH to 
be sensitive to trypsin, but not to reduction with 
borohydride - in common with the results of this 
study where MCH was found to be sensitive to TPCK- 
trypsin but not to reduction with thioglycollate 
(sections 3.1a and e respectively).
These workers were unable to detect MCH in extracts 
of whole brains of Fundulus. Since it would appear 
that they injected equal masses of pituitary and 
brain ( in the form of extracts), it seems that 
they were comparing the concentration (rather than 
the amount) of MCH activity in cod pituitaries with 
that of whole brains of Fundulus. However, MCH 
is concentrated in the hypothalamus (section 2 .2 ,
Fig. 1) and consequently its concentration in whole
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brain is relatively low. This may explain their 
failure to detect MCH in the brain. Alternatively 
the activity of MCH may have been masked by an 
inhibitory factor as was the case in section 3.9 
where the MCH activity of a crude hypothalamic extract 
was undetectable.
4.2 Two forms of MCH in the pituitary
Ion exchange chromatography showed two peaks of MCH 
activity (Fig 8 ), so did HPLC (Fig 4); however, only 
one peak was ever observed on gel-filtration (Figs 3,
10 and 22). Since gel-filtration separates on the 
basis of molecular size,and ion-exchange and HPLC 
on the basis of charge and hydrophobicity respectively, 
it would appear therefore that two forms of MCH exist 
in the pituitary which are the same size but which 
differ in charge and hydrophobicity. We can but 
speculate as to what these differences are but acétylation 
and amidation are obvous possibilities; i.e. the 
existence of acetyl and desacetyl forms as in the the 
case of a-MSH and desacetyl-a-MSH, or of amide and 
acid forms.
4.3 Hypothalmic and pituitary forms of MCH
Many biologically active peptides are biosynthesised 
by proteolytic cleavage from higher molecular-weight 
precursor polypeptides and proteins. To compare 
hypothalamic and pituitary forms of MCH, gel-filtration
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■was used since this gives a clear indication of 
molecular size and would therefore show whether the 
MCH of the hypothalamus might be a precursor of pituitary 
MCH. The molecular-weight of MCH from each source 
was found to be the same (about 1700 daltons, section 
3.10). Thus the MCH bioactivity of the hypothalamus 
was not due to a higher molecular weight precursor.
4.4 Is MCH a neurohypophysial hormone?
Two candidate neurohypophysial hormones are known 
to exist in teleosts : arginine vasotocin (AVT) 
and isotocin or icthyotocin (IT) (see Pickering and 
Heller 1969), however the biological roles of these 
hormones are less well-defined than those of the neuro­
hypophysial hormones of mammals (Sawyer and Pang 1979) . 
Thus MCH could be AVT or IT. Extracts of the pituitaries 
of Lampetra and Xenopus (which contain AVT) are 
devoid of MCH activity, although interestingly, hypo­
thalamic extracts do have MCH activity (Ranee and 
Baker, personal communication). It would appear 
therefore that MCH is not AVT. IT cannot be excluded 
in this way however, because both IT and MCH are 
absent from the pituitaries of all extra-teleostean 
species which have been tested.
All of the known neurohypophysial hormones are nona- 
peptides with a disulphide bridge between cysteine 
r%idues at positions 1 and 6 . Furthermore, the
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integrity of the disulphide bridge is essential to 
their biological activity. Reduction of this bridge 
with thioglycollate results in inactivation (see Vogt 
1 9 5 3 Follet and Heller 1964). In contrast, the 
activity of MCH is insensitive to reduction with 
thioglycollate (section 3.le).
The molecular-weight. of the neurohypophysial hormones 
(all less than about 1 100 daltons) is also incon­
sistent with MCH being a neurohypophysial hormone 
since its molecular weight ( 1700 daltons) is consid^ : 
erably greater than this. These results strongly 
suggest that MCH is not a neurohypophysial hormone.
Biologically active peptides other than the neuro­
hypophysial hormones exist in the hypothalamo-r 
neurohypophysial neurosecretory system of mammals - 
albeit in very much lower amounts than the neuro­
hypophysial hormones; e.g. gastrin -17 (Rehfeld, 1978), 
CCK-8 (Beinfeld et al, 1980), Met - and Leu- enkephalin 
(Martin and Voigt, 1981), dynorphin (1-13) (Goldstein 
et al 1979). It has been suggested that such peptides 
may be involved in the control of the release of 
neurohypophysial hormones (e.g.Rossier et al, 1979) .
Since MCH appears to be present in the hypothalmo- 
neurohypophysial neurosecretory system of teleosts 
and since it does not appear to be a neurohypophysial 
hormone, it may be related to these peptides.
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4.5 The purification of MCHt contamination with MSH
In highly purified preparations of MCH there were 
still appreciable amounts of MSH bioactivity (Table 5). 
Thus it is possible that MCH - in addition to its 
capacity to cause concentration of teleost 
melanophores - also has intrinsic Anolis melanophore- 
dispersing activity. Alternatively, this could be 
due to residual contamination with an MSH-like 
peptide. This uncertainty will always be a problem 
inherent in using pituitaries as a source for the 
purification of MCH because of the great excess of 
Anolis melanophore-concentrating activity which 
exists in pituitary-extracts (in terms of dilution at 
which these activities can be detected in their 
respective bioassays).
It may be possible to avoid this by using hypothalamus 
rather than pituitary as a source for the purification 
of MCH. However, even in the hypothalamus there is more 
MSH bioactivity than MCH bioactivity (Fig 22b).
However, this disparity is not nearly so great as it 
is in the pituitary (Fig 22a) and considering that the 
hypothalamus contains at least as much MCH as the 
pituitary, it probably represents a better source of 
MCH for the purpose of purification.
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4 .6 Do MCH and MSH act at the same receptor?
Pickford and Atz (1957), aware of the disparity 
between the amounts of teleost melanophore-concentrating 
activity and of frog melanophore-dispersing acitivity in 
extracts of teleost pituitary (seen in this case 
with _in vivo bioassays) sought to explain this by 
supposing that MCH and MSH competed with one another, 
and that the observed response in each bioassay was 
a net effect of the two hormones. If this were true, 
then purification of MCH from MSH should result in 
an increase in the apparent acitivity of MCH. This 
was not the case (Table 5) which would suggest that 
MCH and MSH do not compete and may therefore act at 
different receptors. This would argue against 
similarity in the amino-acid sequence of MCH to the 
MSH's.
4.7 MCH as a neuropeptide
There is more MCH in the hypothalamus than in the 
pituitary; even.in the hypothalamus (where MSH is 
considered to be a neuropeptide) there is more MSH 
bioactivity than MCH bioactivity; MCH is detectable 
in the hypothalamus but not in the pituitary of 
Lampetra and Xenopus. These observations (each 
already discussed in a different context) are more 
consistent with MCH being a neuropeptide involved 
in short range communication, rather than it being a 
hormone destined for the general circulation (although
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these roles need not be mutually exclusive). The fact 
that MCH is active on melanophores in no way detracts 
from this possibility, on the contrary; melanophores 
bear more than a superficial resemblance to neurones 
and any substance which is active on melanophores is 
also potentially active on neurones. For example 
MSH: there is now a large amount of evidence which 
would suggest that MSH-like peptides of the brain 
(in addition to other peptides of the pro-opiocortin 
family) function as neuromodulators (see section 4.7).
It is interesting to speculate that MCH might be one of 
the known neuropeptides. Since MCH is present in both 
the hypothalamus and pituitary of teleosts, it may 
be involved in the control of the release of pituitary 
hormones. An obvious candidate role is the control 
of MSH secretion - since both MCH and MSH are found 
in the NIL and since the distribution of MCH between 
hypothalamus and pituitary varies according to 
background (Ranee and Baker, 1979) . However, present 
candidate peptides for the control of MSH secretion - 
which include fragments of oxytocin in mammals (see 
Jackson, 1979), and more recently TRH in the frog 
(Tonon et al, 1980), are too small to be MCH.
Moreover, hypothalamic control of MSH secretion in 
teleosts so far appears to be aminergic (Goos and 
Terlou, 1977) . The activity of MCH is not antagonised 
by Naloxone which would suggest it is not an opiate 
(Dr. B. Baker personal communication).
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4 . 8 Hypothalamic MSH
Peptides of the pro-opiocortin family, including 
a-MSH, have been .identified in the brains of mammals 
by radioimmunoassay, immunocytology, bioassay and by 
chromatographic characterisation. The highest 
concentrations of these peptides are found in the 
basal hypothalamus (as is the case for a number of 
other neuropeptides) and immunoreactive cell-bodies 
are confined to the region of the arcuate nucleus 
(for review see Krieger and Liotta , 1979).
Pro-opiocortin peptides have not yet been identified 
in the brains of teleosts, however, the discovery of 
immunoreactive-a-MSH and bioactive MSH in trout 
hypothalamus would suggest that they exist there 
(section 3.8).
Oliver and Porter (1978) studied the regional dist­
ribution of immunoreactive-a-MSH in the rat brain 
where they found it to be most concentrated in the 
pineal and hypothalamus. They have since shown 
by chromatographic characterization on HPLC that 
this immunoreactive-a-MSH is probably desacetyl- 
a-MSH (Porter et al, 1981) . Gel-filtration on Sephadex 
G-25 of extracts from each region of the brain and 
from the NIL of the pituitary gave similar results; 
immunoreactive-a-MSH and Anolis bioactive MSH co­
eluted in the same position as did synthetic a-MSH
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chromatographed under the same conditions (Oliver and 
Porter, 1980).
Similar results were found in this study when whole 
trout pituitaries were chromatographed on Sephadex 
G-25 (Fig 22a). However, when trout hypothalamic 
fragments were treated in this way, a profound 
difference was observed in the bioactive MSH/immuno- 
reactive-a-MSH profiles; indeed, only a minor part of 
the Anolis bioactivity of the hypothalamus was attrib­
utable to immunoreactive-a-MSH - most of it apparently 
being due to higher molecular weight forms (Fig 22b) . 
This might reflect a different manner of processing of 
the pro-opiocortin precursor in the teleostean 
hypothalamus compared to the PI of the NIL of the 
pituitary, but why this should be so is obscure.
The MSH's are biosynthesised from pro-opiocortin by 
specific proteolytic cleavage via a number of inter­
mediates (see Lowry and Scott, 1977; Eberle 1980).
Each of these, by definition, contains an MSH-sequence 
and as would be expected, these intermediates are 
generally of lower melanotropic potency than the MSH's 
per se (e.g. ACTH, which has very low potency relative 
to a-MSH in the Anolis assay - Tilders et al, 1975). 
Therefore the high molecular-weight bias of the 
molecular-weight distribution of trout hypothalamic 
"MSH” is probably underestimated by the Anolis bioassay.
135
A notable exception to this generalization is p-LPH 
which is about three-times as potent as a-MSH in the 
Anolis assay (Carter et al, 1979). Therefore trout 
p-LPH is an obvious candidate for one of the high- 
molecular- weight forms of hypothalamic "MSH".
4.9 Pituitary MSH
N-terminally shortened forms of desacetyl-a-MBH were 
isolated from unheated extracts but appeared to be 
absent from extracts which had been prepared at 
lOO^C (section 3.5). This suggested that the shortened 
forms were artifacts of non-specific _in vitro proteolysis 
which presumably were produced in the crude extract 
before proteases and MSH's were seperated by chroma­
tography. Similar results were obtained by Lowry 
and Chadwick (1970) who found N-terminally shortened 
derivatives of dogfish (Sgualus acanthias) a-MSH 
which they later concluded were artifacts (Bennet et 
al, 1974). Kawauchi et al (see 1981) have recently 
isolated N-terminally shortened forms of desacetyl- 
a-MSH from salmon (Onchorynchus keta) pituitaries 
but they found only small amounts of these peptides 
relative to desacetyl-a-MSH.
Although extraction in boiling acetic acid might 
produce artifacts,in this study it did not cause 
deamidation or de-acetylation, nor did it hydrolyse 
peptide-bonds of a-MSH. Since acetic acid can easily
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be removed from the extract by lyophilisation, this 
might be a good general method for the extraction of 
basic peptides.
FAB mass-spectrometry proved very useful in the 
identification of purified MSH's and improvements 
in the instrumentation now in progress promise that 
this new technique will be widely used in the future.
4.10 Pro-opiocortin
Two types each of a-MSH (Kawauchi and Muramoto 1979; 
Kawauchi et al, 1980b), p-MSH (Kawauchi and Muramoto 
1979; Kawauchi et al 1980a) and CLIP (Kawauchi et al 
1982) have been isolated from salmon pituitaries.
The sequences of these pairs of peptides show that 
they could not have been derived one from another by 
proteolytic cleavage, and it appears that two distinct 
precursor - i.e. pro-opiocortin - genes are expressed in 
salmon pituitary (see Kawauchi et al 1982).
Liotta et al(1980) have studied the products of 
pro-opiocortin in rat hypothalamus where it appears they 
resemble those of the PI more closely than those of the PD. 
However, it is unknown whether these differences represent 
differing post-translational processing of a common gene 
product, or the expression of different pro-opiocortin 
genes in hypothalamus and pituitary. The occurrence of a 
second pro-opiocortin gene in salmon pituitary is a
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precedent for the latter hypothesis. Duplication of a 
common ancestral gene (perhaps originally expressed only 
in neurones) may have allowed the mutually independent 
evolution of two copies of the gene. It is even possible 
that the second pro-opiocortin gene of salmon is a 
hypothalamic form which - through mutation in gene 
expression - is now expressed in the pituitary also.
It would be interesting therefore to test the peptide 
products of the salmon pro-opiocortins (eg. a-MSH-II) 
for their behavioural effects when administered to the 
brain. Similarly, it would be interesting!to study the 
distribution of these peptides in the brains of-.mammals 
and teleosts by immunostaining. Study of the hormonal 
roles of the respective gene-products in salmonids by 




Attempts to purify MCH from teleost pituitaries 
were unsuccessful. Using the same methods, pure 
undamaged a-MSH's were obtained in high yield. 
Contamination of highly purified MCH with MSH bioactivity 
suggested that the hypothalamus rather than the 
pituitary would be a better source for purification.
The possibility that MCH is a neuromodulator rather 
than a neurohormone indicates that kilogram rather 
than gram quantities of fresh tissue might be necessary 
to purify it. The realization that its activity 
can be masked in crude hypothalamic extracts urges 
caution in deciding whether a tissue lacks MCH and 
this may warrant a re-investigation of its occurrence 
in extra-teleostean species. Many neuropeptides are 
found outside the central nervous system (e.g. TRH 
is found in high concentration in amphibian skin 
(Yasuhara and Nakajima, 1975)) and similarly this 
would urge a re-investigation of its tissue-occurrence.
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